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                                           1. INTRODUCTION 
  Siddha system is one of the earliest traditional medicine systems in the world. It is 
mainly practiced in the southern part of India. The term Siddha means an achievement. 
The practitioners of this medicine system are called Siddhars. They need to attain the 
physical, psychological, social and spiritual excellence to be able to treat people 
(1)
. 
  The roots of this system are intertwined with the culture of ancient tamil 
civilization. Herbal preparation are mostly preferred as the primary choice of medicines 
for various ailments, which is confirmed by the following literature quote
 (2)
. 
Siddhars were the people who aimed for spiritual perfection to reach the ultimate 
goal of life. They were the greatest scientists who were supposed to have lived at a very 
early period. Siddhars were highly spiritual and intellectual personalities combined with 
supernatural powers that have the knowledge of healing art in curing many diseases of 
the mankind.
 
 Siddha medicine aims at the perfection of health. Siddhars the concept of how a 
human body is exposed to various types of diseases. 
             The main principle is that the human body constituted with three basic humours 
named as Vadham, Pitham and Kabam which on derangement leads to diseased 
conditions or ill health and the deranged Vatham, Pitham, and Kabam are termed as 
“Three Doshas”.
(3)
 
             The three humours are considered are three pillars of health and support the 
structure and functions of the body. These three humours are involved in regulating all 
the function of the body and maintain the balance in the physical, emotional and mental 
spheres. 
             The imbalance of humours especially kabam and vadham in Respiratory system 
modifies the air passage by secreting inflammatory mediators causing broncho 
constriction,  suddenly leading to difficulty in breathing. Siddhars described this 
condition in literatures and named it as “Swasakasam or Iraippu”. The symptoms of the 
disease Swasakasam are related to “Bronchial Asthma” 
(4)
. 
            According to World Health Organisation (WHO) Bronchial Asthma is 
inflammatory disease of the airways of the lungs. It is characterized by variable and 
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recurring symptoms reversible airflow obstruction and bronchospasm. Symptoms include 
episodes of wheezing, coughing, chest tightness and shortness of breath 
(5)
. 
            World Asthma day is an annual event organized by Global Initiative for Asthma 
(GINA) to world. World asthma day takes place on the first Tuesday of May 
(6)
. 
             As per ECRHS (European Community Respiratory Health Society) and ISAAC 
(International Study of Asthma & Allergies in childhood) the prevalence of Asthma 
increased steadily over the later part of the 20th century. About 300 Million people 
around the world wide suffer from Bronchial Asthma. India has been estimate to range 3-
38% children and 2-12% in adults being the commonest chronic disorder among children 
(5)
. 
            A recent India Study on Epidemiology of Asthma Respiratory Symptoms and 
Chronic Bronchitis (INSEARCH) done with 85,105 Men and  84,470 Women from 12 
Urban and 11 Rurel sites  in india to be 2.05 % among those aged >15 years with an 
estimated national burden of 18 million asthmatics 
(7)
. 
            Although the development, course of disease and response to treatment are 
influenced by genetic determination, the rapid rise in the prevalence of asthma implies 
that environmental factors are critically important in terms of its expression. 
            Status Asthmaticus, secondary infection such as Bronchitis and Tuberculosis, 
Emphysema of lungs, later stage of Right Heart Failure called Chronic Cor Pulmonale, 
Bronchiectasis, Pneumothorax, Pneumo mediastinum are the complication of Bronchial 
Asthma. 
             Acute severe Asthma is termed as Status Asthmaticus is a medical emergency 
condition which is characterized by Tachycardia, Tachypnoea, Sweating, Pulses 
paradoxus and altered level of consciousness life threatening factors of Bronchial Asthma 
are central cyanosis, silent chest, severe hypoxaemia and altered consciousness 
(8)
. 
             According to who, mortality due to asthma is not comparable in size to the day to 
day effect of disease. Although largely avoidable. Asthma tends to occur in epidermics 
and affects young people. Worldwide the death from this condition has reached over 
180,000 annually. 
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              Asthma cannot be cured but could be controlled controlling asthma needs a good 
bronchodilator and also to control the hypersensitivity reaction. The famous 
bronchodilator drugs in market are Salbutamal, Theophylline, Isoprenaline etc… These 
drugs give only temporary relief to the patient with the reoccurrence of this disease and 
thereby causing adverse effect. For example, salbutamol causes some adverse effects 
such as muscle tremors, palpitation, restlessness and nervousness. Theophylline causes 
convulsion, shock and insomnia. Isoprenaline produce tachycardia 
(9)
. 
               Inhaled corticosteroids also increase the risk of cataracts (clouding of the eye 
lens) and osteoporosis (weakening of the bones) if taken for long periods of time
 (10)
. 
               Hence a safe and strong bronchodilator drug is needed. An internal medicine 
with remarkable efficacy is needed to administer to the affected individual. 
               Some of the popular Siddha drugs given for Bronchial Asthma are 
Mahavasantha  kushmagaram,  Poorna chendrodhayam, Swasakudori mathirai, Thalisathi 
chooranam, Pavala  parpam, Arrakku thailam etc……
(4)
. 
                  To control bronchial Asthma the world requires safety traditional fast acting 
 Bronchodilators and potential drugs having anti-histamine activity to control the 
hypersensitivity reaction without any side effects. 
                In Siddha,  purely herbal formulation provides biosafe and relieves the broncho 
constriction and other symptoms by their fast acting properties. They do not possess any 
adverse drug reactions. The author was interested in administering herbal preparation 
“KANDANKATHARI CHOORANAM” an effective bronchodilar or indicated for 
Bronchial Asthma in the siddha literature “AGATHIYAR ATTAVANAI VAGADAM” 
(11)
. 
               In this preparation most of the medicinal plants have bronchodilator activity, for  
example Toddalia asiatica (Milagaranai), Solanum xanthocarpum (Kandankathari), 
Zingiber officinale (Chukku) and Piper nigrum (Milagu). Anti histaminic plant in the 
preparation is piper longum. 
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  Hence all these enriched plants used especially for many respiratory diseases are  
combined together in this herbal formulation “KANDANKATHARI  CHOORANAM” 
will be used as bronchodilator in treating bronchial asthma (Swasakasam or Iraippu). Still 
now no scientific research works have been carried out on this herbal preparation. 
Therefore the author is interested to conduct Bronchodilator, Anti-Histamine and Anti-
Oxidant activity of “KANDANKATHARI CHOORANAM” for Bronchial Asthma. 
        
         
          
                    
                 
                
  
 
 
 
 
 
 
AIM AND 
OBJECTIVES 
AIM AND OBJECTIVES 
 
BRONCHODILATOR ACTIVITY OF KANDANKATHARI CHOORANAM Page 5 
 
                                          2. AIM AND OBJECTIVES  
AIM  
The aim of this dissertation is to establish the Scientific Validation of the 
Bronchodilator, Anti-Histamine and Anti-Oxidant property of Kandankathari 
Chooranam  for Bronchial Asthma.  
 
OBJECTIVES  
The main objective of the present study is to highlight the efficacy of 
Kandankathari Chooranam. The following methodology was adopted to evaluate the 
drugs and its standardization studies  
 Collection of various Siddha and modern literature relevant to the study.  
 Identification of the drugs in this formulation.  
 Preparation of Kandankathari Chooranam as per the classical Siddha 
literature.  
 Physicochemical and phytochemical investigation of the test drug.  
 Evaluate bio-chemical analysis of the test drug to derive acidic and basic 
radicals.  
 To estimate the present of elements, functional groups and particle size 
through instrumental analysis of the trial drug.  
 Evaluation of the Acute and 28 days repeated dose oral Toxicity of test drug 
according to OECD guidelines.  
 Evaluation of pharmacological study of the drug through the following 
activities  
 Evaluation of Bronchodilator activity  
 Evaluation of Anti- histamine activity  
 Evaluation of Anti -oxidant activity of Kandankathari Choornam.  
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3. REVIEW OF LITERATURE 
DRUG REVIEW 
  
             The trial drug “Kandankathari Chooranam” was taken from the Siddha literature 
“Agathiyar Attavanai Vagadam” for treating Bronchial Asthma. The ingredients of the 
drugs   are. 
                         1. Kandankathari Root (Solanum xanthocarpum) 
                         2. Araikeerai (Amaranthus tristis) 
                         3. Chukku (Zingiber officinale) 
                         4. Thippili (Piper longum) 
                         5. Milagu (Piper nigrum) 
                         6. Milagaranai pattai (Toddalia asiatica) 
                         7. Sugar ( Saccharum officinarum)  
                         8. Ghee 
3.1. GUNAPADAM REVIEW  
                                                 KANDANKATHRI 
                   Scientific Name  : Solanum xanthocarpum  
                   Synonyms                  : Solanum surattense .Burm. f. 
                                                                     Solanum virginianum (12A).. 
                 Vernacular Names  
Tamil                  : Kandangkattari 
                      English                : Wild egg plant, Bitter sweet woody nightshade, 
                                 Yellow berried night shade 
                      Telugu                  : Nela Mulaka-Vakudu 
               Malayalam           : Vellottuvalutina 
                      Hindi                    : Kateli  
REVIEW OF LITERATURE 
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                     Sanskrit                : Kanta-karika  
                 Kannadam            : Nela-gulla                         
Parts Used        : Leaf, flower, root, fruit, seed 
       Properties: 
                       Suvai (Taste)                        : Karppu  
   Thanmai (Nature)                  : Veppam  
      Pirivu (Bio- Transformation) : Karppu 
        Actions:  
 Expectorant  
 Diuretic  
 Carminative  
General Characters:                 
         “காச சுவாசங் கதித்தக்ஷய மந்தமனல் 
           வசீுசுரஞ் சன்னி விளைததாடம் – ஆசுறுங்கால் 
           இத்தளரயு ணிற்கா எரிகாரஞ் தசர்க்கண்டங் 
           கத்திரியுண் டாமாகிற் காண்.” 
- அகத்தியர் குணபாடம் 
 
Indications              : It cures Cough, loss of appetite and Asthma.  
Therapeutic Uses    : 
 A decoction of the leaves and roots with long pepper in the dose of half to one 
ounce with honey was an excellent mixture used in chronic bronchitis and 
asthma.  
 Juice of berries are beneficial in sore throat.  
 Leaf juice in a combination with black pepper prescribed in Rheumatism.  
 Root decoction in combination with Tinospora cordifolia was useful in cough 
and fever. 
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ARAIKEERAI 
  Scientific Name                 :    Amaranthus tristis 
  Synonyms                          :    Spleen amaranth 
                                                   Amaranthus dubius 
(12B)
. 
 Vernacular Names 
                Tamil                   : Araikeerai 
                English                : Pig weed amaranth 
                Spanish                : Bledo de jamaica 
                French                 : Brede de Malabar 
 Parts used           :  Whole plant 
 Properties           : 
            Suvai (Taste)                               : Inippu (Sweet) 
           Thanmai (Nature)                        : Veppam 
            Pirivu (Bio – Transformation)    : Inippu (Sweet) 
 Actions: 
 Stimulant 
 Aphrodisiac 
 Laxative 
 Diuretic 
 
 General Characters: 
                   “காய்ச்சல் குைிர்சன்னி கபத ாய் பலபிணிக்கும் 
        வாய்ச்ச கறியாய் வழங்குங்காண் – வசீ்சாய்க் 
        கறுவுதமா வாயுவினங் காமமிக வுண்டாம் 
        அறுகீளர ளயத்தின் றறி”. 
- பதார்த்த குண சிந்தாமணி 
 
Indications: 
 It cures Anaemia, Haemorrhage and Constipation 
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Therapeutic Uses: 
 Leaves in general are recommended as a good food with medicinal properties 
for young children, lactating mothers and for patients with Fever, 
Haemorrhage, anaemia, Constipation and Kidney complaints. 
 The whole plant is used as a medicine against stomach ache.  
 
 
CHUKKU 
Botanical name         :   Zingiber officinale 
Synonyms : Nagaram, Atagam, Aartharagam, Chowpannaum, Verkombu,                                                              
Nava suru, Ullarntha inji, Vidam moodiya amirtham.
(12C)
 
Vernacular names 
        Tamil                   :  Chukku 
        English                :   Dried ginger 
        Telugu                 :   Sonti 
        Malayalam          :   Shukka 
        Kannadam           :   Ona shunti or Sunti 
        Sanskrit               :   Nagaram 
        Hindi                   :   Sonth 
Part used                    :   Dried Rhizome 
Properties 
       Suvai (Taste)                               :    Karppu 
       Thanmai (Nature )                       :    Veppam 
       Pirivu (Bio-Transformation)       :    Karppu 
 
 Actions 
 Stimulant 
 Stomachic 
 Carminative 
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General Characters 
         “சூளலமந்தம் ந ஞ்நசரிப்பு ததாடதமப் பம்மழளல 
         மூலம் இளரப்பிருமல் மூக்கு ீர் – வாலகப 
         ததாடமதி சாரந் நதாடர்வாத குன்ம ீர்த் 
         ததாடம்ஆ மம்தபாக்குஞ் சுக்கு.” 
- அகத்தியர் குணபாடம் 
Indications 
 Dried ginger was used for Indigestion, Gastric irritation, Anal diseases, Asthma, 
Cough, Diarrhoea, Sinusitis, Anaemia and Fever. 
Therapeutic uses 
 A pinch of dried ginger powder with cow’s milk is useful in loss of appetite. 
 Dried ginger powder with sugarcane juice reduces burning sensation of the 
stomach. 
 Dried ginger with sugar candy powder taken with tender coconut in morning and 
evening for dyspnoea and chest pain after heavy working. 
 Dried ginger decoction is useful for poisonous type of fever. 
 Chewing a piece of dried ginger helps in relieving the tooth ache.
(13A)
 
 
THIPPILI 
Botanical name      :  Piper longum 
Synonyms               : Pippli, Aadhi,Kaaman, Sowndi, Kanam, Saram, Koli, Ambu, 
                                  Aathimarunthu, Kanai.
(12D)
. 
Vernacular names: 
            Tamil                :  Thippili 
            English             :  Long pepper 
            Telugu              :  Pippilu 
            Malayalam       :  Thippili 
            Kannadam        :  Hippili 
            Sanskrit            :  Pippali 
            Hindi                :  Pipar 
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Part used                     : Dried fruit and Roots 
Properties 
         Suvai (Taste)                           :    Karppu 
         Thanmai (Nature)                    :   Veppam 
         Pirivu (Bio- Transformation)  :   Karppu 
Actions 
 Carminative 
 Stimulant 
 Expectorant 
 Antiseptic 
 Febrifuge 
General characters 
 “                        
                         -        
                                     
                                 . 
                              - ததரன் நவண்பா 
Indications 
 It relieves Kapha related diseases and strengthens the body.  
Therapeutic uses 
 Powered long pepper with honey will relieve cough, cold, asthma, 
hoarseness and hiccough. 
 Long pepper powder with honey and betel leaf juice cures fever. 
 A mixture of long pepper, long pepper root, black pepper and ginger in 
equal proportions is used to relieve colic and flatulence. 
 Powered form of long pepper seeds with ghee is used for its aphrodisiac 
action 
(13B)
. 
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MILAGU 
Botanical name          :   Piper nigrum 
Synonyms                   :  Malayali, Maasam, Sarumabandam, Kaayam, Kalinai, Miriyal,  
                                       Thirangal 
(12E)
. 
Vernacular names 
                 Tamil                  :   Milagu 
                 English               :   Black pepper 
                 Telugu                :   Miriyalu 
                 Malayalam         :   Kurumilagu 
                 Sanskrit              :   Maricha 
                 Hindi                  :   Kali-mirch 
 Part used            :  Dried fruits 
 Properties 
                Suvai (Taste)                           : Kaippu, Karppu 
                Thanmai (Nature)                    : Veppam 
                Pirivu (Bio- Transformation)  : Karppu 
  Actions 
 Carminative 
 Stimulant 
 Anti-vadha 
 Antidote 
General characters 
                             “சீதசுரம் பாண்டு சிதலத்மங் கிராணிகுன்மம் 
               வாதம் அருசிபித்தம் மாமூலஓது – சன்னி 
               யாசமபஸ் மாரம் அடன்தமகம் காசமிளவ 
                ாசங் கறிமிைகி னால்”. 
                                      - அகத்தியர் குணபாடம் 
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Indications 
  It cures Anaemia, Gastric ulcer, Giddiness, Diarrhoea, Dysentery, Vomiting, 
              Anal fissure and Cataract.  
Therapeutic uses 
 Dried unripe fruits are prescribed  in cholera, dyspepsia, flatulence and various 
gastric ailments. 
 Powdered black pepper with onio and salt is made into a paste, and this mixture is   
applied on the scalp to cure alopecia and also to increase the hair  growth. 
 Black pepper paste is applied externally for boils. 
 Powder of black pepper is used as tooth powder 
(13C)
. 
 
MILAGARANAI 
Botanical names :  Toddalia asiatica 
Synonyms                  :  Toddalia aculeate pers 
                                         Paullinia asiatica 
(12F)
. 
Vernacular names 
           English             :    Forest pepper 
                                         Wild orange tree 
                                         Lopez-root tree 
            Malayalam      :     Milakaranai 
 Sanskrit :     Kanchana 
 Hind     :     Jangli – kalimirch 
            Telugu             :     Konda-kashinda 
            Kanadam        :     Kada-hakukare 
 Bengali :     Dahana 
Parts used  :   Leaf, Bark, Root. 
Properties 
            Suvai (Taste)                     : Thuvarppu  
 Thanmai (Nature)         : Thatpam  
 Pirivu (Bio – Transformation) : Kaarppu 
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Actions 
 Stimulant 
 Tonic 
 Carminative 
 Diaphoretic 
 Antiperiodic 
General characters: 
                   “ஐயம கற்றும் அசீரணவா தம்தபாக்குஞ் 
             நசய்யபித்த சூளலகளைத் தீர்க்குங்காண் - ளபயவரும் 
             ஈளை இருமல் இளரப்புப்பு சந்நதாளலக்கும் 
               ாளு மிைகரளண  ன்று”. 
- அகத்தியர் குணபாடம் 
Indications : 
 It cures Indigestion, Cough, Bronchial asthma and Stomach ailments. 
Therapeutic uses: 
 The fruits are used as a cough remedy. 
 The leaves are used for lung disease and rheumatism. 
 The roots in the treatment of indigestion and influenza. 
 The root bark is used medicinally as a tonic and for stomach ailments 
(14)
. 
ASSOCIATED DRUGS: 
                                              GHEE ( Nei ) 
            Butter is cleaned and heated in a vessel. When it melts either the leaves of 
Moringa olifera or the bettle leaves are added and filtered immediately, since it is 
difficult to filter after cooling. 
           If Ghee is preserved in a good vessel, it won’t spoil upto months. Cow’s ghee is 
slightly yellowish in colour. Ghee should be forbidden. It is good to consume the melted 
ghee and diluted butter milk. The following lines stress these points: 
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          “                  ந ய் ருக்கி          
                            ”. 
-                    (14) 
 
General properties: 
             “ந ய்யுண வுண்டளவ த ர்வுறச் நசய்துதமன் 
        நமய்ளயயுந் திண்ணிய தமருநவனச் நசய்யும்.  
- குணபாடம் தாதுசீவவகுப்பு (15). 
 When ghee taken in required quantities along with usual diet, it helps in proper 
digestion and utilization of the diet and gives strength and vigor to the body. 
Cow’s ghee: 
 It controls thirst, Vomiting, Excessive Pitha, Burning sensation of the stomach, 
Pitha hi-cough, Abdominal pain, Dryness, Pricky heat, Cough, Hypermotility of the gut, 
Weakness of bones, Piles etc. 
Medicinal uses: 
 When ghee is mixed in hot rice and eaten, it enhances the healing of peptic ulcer. 
It also stimulate bone marrow growth. Ghee should be eaten only after melting 
(liquid form) 
 Dried ginger, Pepper, Cuminum seeds are fried, powdered and taken along with 
ghee for indigestion and dysentery. 
 For curing stomach pain, the ghee is taken with boiled rice water and if it is taken 
with palm sugar candy, it cures body heat and whooping cough. 
 Ghee is also used as an adjuvant for many parpams, Chendhoorams, Leghium, 
and Thailams . 
 By taking ghee bath, the burning sensation, pitha, Unconsciousness, 
Haematemesis etc. are cured.
(16)
. 
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SUGAR (SARKARAI) 
Botanical name :  Saccharum officinarum 
Synonyms                  : Punarpoosam, Ikku, Vei 
(12G)
. 
Vernacular names 
            Tamil                 :     Karumbu 
 English              :     Sugarcane, Noble cane  
            Telugu    :     Cheruku  
 Kannada   :     Karinpa  
 Malayalam   :     Khabbu 
Parts used: 
            Sugarcane juice, Sugar, Root 
Properties and uses  
 Taste(Suvai)           : Inippu (Sweet)  
 Nature(Potency)       : Thatpam (Cold potency)  
 Division(Pirivu)       : Inippu (Sweet) 
Action   
 Demulcent 
 Antiseptic 
 Stimulant 
 Diuretic 
 Nutrient 
General characters: 
              “சீனிச் சர்க்களரக்குத் தீராத வன்சுரமுங் 
         கூனிக்கும் வாதத்தின் கூட்டுறவும் – ஏனிற்கும் 
         வாந்தி நயாடுகிருமி மாறாத விக்கலுதம 
         தபாந்திளசளய விட்டுப் புரண்டு”. 
- அகத்தியர் குணபாடம் 
Indications: 
 It can be used as an adjuvant for several medicine 
 It cures vomiting. 
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Therapeutic uses: 
 It cures Fever, Vomiting and Hiccough. 
 It cures Vadha fever, Common cold and Sinusitis. 
 Paste of sugar with bee wax  is used to treat acne. 
 It cures eye diseases. 
 
3.2. BOTANICAL REVIEW  
 
KANDANKATHARI (Solanum xanthocarpum) 
Scientific classification 
(17)
 
 
                        
Kingdom : Plantae                                             
 
                        Class : Dicots                                                      
                        Order : Solanales 
                        Family : Solanaceae 
                        Genus : Solanum  
                        Species : xanthocarpum 
Distribution: 
              Grown abundantly in India Common in road sides waste places and along 
railway lines throughout India. 
Description : 
              A prickly diffuse perennial herb. Numerous branches. Leaves ovate or elliptic 
sinuate or subpinnatifide glabrescent, with many straight spines. Flowers borne in few 
flowered lateral cymes. Corolla blue, lobes shallow, Fruits globose, glabrous berries, 
Whitish and green blotched, yellow when ripe. Seeds glabrous. 
                    Flowers and fruits during March – July 
(18A) 
 Parts used: 
                    Leaf, Flowers, Fruits, Seeds, Root. 
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 Chemical Constituents: 
     Carpesterol, Gluco-alkaloid solanocarpine, Solanine-S, Solasodine, Solasonine, 
Solamargine, Cycloartanol, Cycloartenol, Stigmasterol, Campesterol, Cholesterol, 
Sitosteryl-glucoside, Stigmasteryl-glucoside, Solasurine 
(19)
. 
Properties: 
                The plant is Acrid, Bitter, Digestive, Alternative, Astringent, Expectorant, 
Diuretic, Carminative, Hydragogue, Antifilarial and Hepatoprotective. 
Uses: 
 Root decoction used as febrifuge, effective diuretic and expectorant. 
 The whole plant is used traditionally for curing various ailments. 
 Decoction of the plant is used in gonorrhea. 
 Paste of leaves is applied to relieve pain 
(20)
. 
 
ARAIKEERAI (Amaranthus tristis) 
 
 Scientific classification 
(21)
 
 
                       
Kingdom : Plantae                                         
                       Class : Dicots                             
                       Order : Caryophyllales  
                       Family : Amaranthaceae 
                       Genus : Amaranthus 
                       Species : tristis 
 Distribution: 
  A.tristis is Native to South America, Mexico and the West Indias and naturalized 
or invasive in the USA, central and Southwest Africa, Asia. 
  It is cultivated in many countries especially in Africa, but it can be difficult to  
know whether its presence in a country is only as a cultivated plant or as a 
naturalized plants. 
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Description: 
 Annual herb, 10-100 cm tall glabrous or sparsely pubescent in distal parts. Stems 
erect, green, branched 0.3-1mm 
 Leaves petiole of proximal leaves equaling or longer than blade, becoming 
Shorten distally. Stipules absent. 
 Inflorescences terminal panicles and axillary spikes. Panicles erect or often 
drooping, green, dense branched, leafless at least distally. 
 Bracts lanceolate, shorter than 2mm pistillate flowers tepals  5, oblong-spathulate 
to oblong, not clawed, very shortly mucronate, yellowish. 
 Seeds dark reddish brown to black, lenticulate, 0.8-1mm diameter, shiny, smooth. 
Chemical constituents: 
        Acifluorfen, atrazine, bensulfuron, butachlor, chlorthal-dimethyl, dimethametryn, 
diphenamid, diuron, glyphosate, metribuzin, oxadiazon, oxyfluorfen, paraquat, 
pendimethalin, propanil and trifluralin. 
  Parts used: 
                     Whole plants 
  Properties: 
                     The plant is Acrid, Laxative, Diuretic. 
  Uses: 
 Leaves in general are recommended as a good food with medicinal properties for 
young children. 
 Seeds and oil have fiber which contributes to lower cholesterol and risk of 
constipation.  
 It is rich in phytosterols and also known for lowering cholesterol. 
 The leaves are high in vitamin C, Vitamin A and Folate. 
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CHUKKU (Zingiber officinale) 
 Scientific classification 
(22) 
                        Kingdom : Plantae 
                        Class             : Monocholamydeae                               
                        Order    : Zingiberales 
                        Family : Zingiberaceae 
                        Genus : Zingiber 
                        Species : officinale 
 
Distribution: 
               Cultivated throughout India, run wield in some places in the Western Ghats.  
 
Description 
              A Slender, perennial rhizomatous herb; leaves linear, sessile, glabrous; 
flowersyellowish green in oblong, cylindrical spikes, en-sheathed in a few scarious, 
glabrous bracts; fruits along capsules. The rhizomes are white to yellowish brown in 
colour, irregular branched, somewhat annulated and laterally flattened. The growing tips 
are covered over by a few scales. The surface of the rhizome is smooth and if  broken a 
few fibrous elements of the  vascular bundles project out from the cut ends 
(23)
. 
 Parts used: 
              Rhizome 
Chemical Constituents 
              The characteristic fragrance and flavor of ginger result from volatile oil that 
compose 1-3%of the weight of the fresh of ginger, primarily consisting of zingerone, 
shogaols and gingerols with gingerol as the major pungent compound. Zingerone is 
produced from gingerols during drying, having lower pungency and a spicy-sweet aroma 
(24)
. 
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Properties:  
             The dry ginger is Acrid, Thermo-genic, Emollient, Appetiser, Laxative, 
Stomachic, Stimulant, Rubefacient, Aphrodisiac, Expectorant, Anthelmintic and 
Carminative. 
Uses: 
           It is useful in Dropsy, Otalgia, Cephalic, Asthma, Cough, Colic, Diarrhoea, 
Anorexia, Dyspepsia, Cardiopathy, Cholera, Nausea, Vomiting, Elephantiasis and 
Inflammation. It is also much used in several domestic preparations 
(25)
. 
 
THIPPILI (Pipper longum) 
Scientific classification
 (26) 
                     Kingdom : Plantae 
                     Class : Magnolipsida                            
                     Order : Piperales 
                     Family : Piperaceae 
                     Genus : Piper 
                     Species : longum  
 
 Distribution 
        This plant mostly occurs in hotter parts of the India from central Himalayas to        
Assam up to lower hills of the west Bengal and evergreen forests of western Ghats as 
wild and also cultivated in north east and south. It grows in Kurinji nilam. 
Description of the plant 
      A slender aromatic climber and leaves alternative, lower ones broadly ovate cordate, 
upper ones oblong, oval, all entire 5 to 7 nerved leaves; male spikes longer, slender, 2.5 
to 7.5 cm long. Female spikes short, cylindrical, 1.5 to 2.5 cm long, 5 to 7 mm thick. 
Fruit greenish- black to black, cylindrical, 2.5 to 5 cm long and 0.4 to 1 cm thick, 
consisting of minute sessile fruits, arranged around an axis. Surface rough and composite; 
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broken surface shows a central axis and 6 to 12 fruitlets arranged around an axis. Odour 
is aromatic; taste is pungent producing numbness of the tongue 
(27A)
. 
Parts used:  
           Roots, Dried spikes. 
Chemical constituents: 
       Volitale Oil, Resin, Piperin, Piperlongumine, Piperlatin, Brachyamide A, 
Brachyamide B, Brachystine, Sterols, Glycosides 
(28)
. 
Properties: 
          The roots are bitter, Tonic, Diuretic, Purgative, Expectorant, Stomachic, Digestive 
and Emmenagogue. 
Uses: 
 They are useful in Gout, Dyspepsia, Stomachalgia and Spleenopathy. 
 It cures Anorexia, Dyspepsia, Asthma, Bronchitis, Hiccough, Epilepsy, Fever, 
Gonorrhoea, Haemorrhoids and Lumbago 
(29)
. 
 
MILAGU (Piper nigrum) 
 Scientific classification 
(30)
   
                        
   
Kingdom : Plantae 
                           Class : Dicot 
                           Order : Microembreye                               
                           Family : Piperaceae 
                           Genus : Piper 
                           Species : nigrum 
 
Distribution 
             The plant cultivated in the hotter and moist parts of India, in evergreen forest up 
to 1,500 meters. 
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Description 
          Climbing perennial shrubs, rooting at the nodes, leaves are cordate or round based; 
flowers minute in spikes usually dioeciously. Fruiting spikes very variable in length, 
fruits ovoid or globose one seeded berries, bright red when ripe, seeds are globose, 
albumin hard and testa thin greyish-black to black, perisperm hard, wrinkled and white, 
0.4 to0.5 cm in diameter; odour aromatics, taste pungent. 
         Flowering occurs in the rainy season and fruits ripening in the autumn season 
(December to April) 
(27B)
. 
Parts used: 
         Dried fruits. 
Chemical Constituents 
         Piperine, chavicine, Piperettine, Piperoline A&B, Trichostachine, N-trans-feruloyl 
 piperidine, Feruperine, Citrohellol, Arginine, Piperolic acid, Serine, Ascorbic acid, 
 Carotene 
(31)
. 
Properties: 
          The fruits are Acrid, Bitter, Anthelmintic, Carminative, Aphrodisiac, Antiperiodic, 
 Diuretic, Digestive, Emmenagogue, Stimulant  and Stomachic. 
Uses: 
 They are useful in Arthritis, Asthma, Fever, Cough, Dysentry, Dyspepsia, 
Hiccough, Haemorrhoids and Dermatopathy 
(32)
. 
                    MILAKARANAI (Toddalia asiatica) 
Scientific classification 
(33)
 
Kingdom            : Plantae 
Class                   : Dicot 
            Order                  : Sapindales 
            Family                : Rutaceae 
            Genus                 : Toddalia 
            Species               : asiatica 
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Distribution: 
            Found in sub-tropical Himalayas, from Kumaon eastwards to Assam, Khasi hill 
and throughout the Western Peninsula. 
Description: 
             A throny, scandent shrub, Leaves 3-foliolate; leaflets sessile, elliptic, obovate, 
oblongor lanceolate, crenulate, coriaceous, Flowers white, borne in axillary, compressed 
cymes; calyx glandular. Fruits globose, 3-5-grooved, orange- coloured, 3-5-celled. Seeds 
solitary in  each cell. 
           Flowers during February- March and fruits during May- June. 
Parts used: 
             Leaf, Bark, Root. 
Chemical constituents: 
              Berbapten, norbraylin, 5,7,8-trimethoxycoumarin, dictamnine, luvangetin and  
robustin(stem); hexacosanoic acid, arnottainamide, dihydroavicine, 8-acetoxy, 
aculeatin,diosmin, phnanthridine, isopimpinellin, pimpinellin, toddaculine, toddanol, 
toddanone, and toddasin . 
 Properties: 
            Plant leaves and stem have bitter taste, minty and warming- nature and considered 
 antiphlogistic and analgesic in nature. 
            Root bark of the plant is Antimalarial, Antiperiodic, Antipyretic, Tonic and 
Carminative. 
Uses: 
          Toddalia asiatica is widely used by many African tribes 
 It is used for treatment of Malaria Cough and Influenza. 
 It is used as a pain killer. 
 Leaf essential oil is used in relieving Rheumatic arthritis, Sprains and Contusions. 
 Intercostals neuralgia, Cough, Malaria, Dysentery and Gastralgia 
 It is also used as an antidote against poisonous Snakebite, Nausea, Bronchitis, 
Wounds. Contaminated Ulcers, Epilepsy, Gonorrhea and General Debility 
(34)
.  
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ASSOCIATED DRUGS: 
                      
                          GHEE                          
English name: 
          Ghee, Clarified butter.   
 
 
                                                    
Nutritional profile: 
 
 Ghee is relatively high in calories, containing 112 calories per tablespoon serving, 
A serving contains 12.7 grams of fat, minimal amounts of protein and no 
carbohydrates dietary fiber or sugars. 
 Ghee is high in saturated fat with 7.9 grams per serving. 
Vitamins and Mineral content: 
 It contains only a minimal amount of calcium 1mg/tsp Ghee also contains 108 
micrograms of vitamin A, which is a significant amount for such a small serving 
size. 
 1 tsp provides 12 and 15% of the recommended daily intakes of vitamin A for 
men and women, respectively 
(35)
. 
SUGAR ( Saccharum officinarum ) 
Scientific classification  
                      Kingdom : Plantae 
                      Class : Monocotyledons                
                      Order : Poales 
                      Family : Poaceae 
                      Genus : Saccharum 
                      Species : officinarum 
 
REVIEW OF LITERATURE 
 
BRONCHODILATOR ACTIVITY OF KANDANKATHARI CHOORANAM Page 26 
 
Distribution: 
               Sugar cane is indigenous to tropical south and southeast Asia. 
Description: 
              It is a topical, perennial grass that forms lateral shoots at the base to produce 
multiple stems, typically three or four meters high and about 5 cm diameter and once 
harvested the stalk will regrow allowing the plant to live for between 8 to12 years. The 
stem grows into cane stalk, which when mature constituents approximately 75% of entire 
plant. A mature stalk is typically composed of 11 – 16% fiber, 12- 16% soluble sugars, 2-
3% non-sugar and 63-73% water. The leaves are grow from the nodes of the stem, 
arranged in two rows on either side of the stem. The leaves are tubular and blades like, 
thicker in the centers than at the margins panicle which possesses two spikelet and seeds 
protected by husks covered in silky hair. 
Parts used: 
           Roots,  Stems 
(36A) 
Chemical constituents: 
   Sucrose is the product of the sugar cane juice. The juice yielded flavones 
diosmetin-8-C-gulcoside, vitrexin, schaftoside, isoschaftoside and 4’,5’-dimethyl-
luteolin-8-C glucoside 
(37)
. 
Properties: 
       The roots are cooling and diuretic. The stems (sugar cane) are Sweet, Cooling, 
Emollient, Laxative, Cardio- tonic, Diuretic, Galactogogue, Aphrodisiac, Expectorant, 
Haemostatic and tonic. 
 
Uses: 
 The roots are useful in Uropathy. 
 They are useful in Dipsia, Fatigue, Leprosy, Gastropathy, Cardiac, Debility, 
Hamatemesis, Cough, Bronchitis, Anaemia, Ulcers of the skin and mucous 
membrane. Seminal weakness, Emaciation and general debility 
(36B)
. 
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 3.3. SIDDHA ASPECT OF THE DISEASE 
                                            SWASAKASAM  (BRONCHIAL ASTHMA) 
Other Names 
 Iraippu 
 Izhuppu noi 
 Swasam 
 Thoivu
 Eelai
 Suram
 Iraippirumal
Nature of the disease 
               Swasakasam arises with severe chest tightness leading to difficulty in inspiration 
and expiration of the air (i.e. dyspnoea). In addition to difficulty in breathing while 
exhaling the air, expiratory noise will be produced resembling the sounds of musical 
instruments like flute, veena, etc., are heard obviously. Further if hard attempts are made 
to expel the phlegm, it results in vain. 
Genesis of the disease 
“கால்நபருக் குணவுநபாருள் தண்ணரீ் மாறல் 
கருதிருமல் மிகல்வாந்தி குைிர்ந்த காற்று 
மால்நசய்து  ாள்ததாறும் வருந்துங் காய்ச்சல் 
மந்தன முயிர் ிளல யிலடிகள் தாங்கல் 
ஏல்சீத தபதிவிட பாண்டு புளககள் 
இலகிய ந ல்லாதிமணிச் சுளனயுட் நசல்லல் 
தமல்வழியிற் சிலவரினு மிளரப்பாம் த ாயு 
முனிவர்கள் விைம்பினாதர” 
- ளகநயழுத்துப்பிரதி 
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  Swasakasam is caused due to the following factors such as 
 Ingestion of allergic food stuffs
 Allergy inducing activities such as exposed to cool climates.
 Immunity deprivation
 Intake of diet which increases kapha.
 Grass, rice and ragi also triggers the signs and symptoms
 Symptoms may also develop due to inhalation of foul smelling substances.
Prodromal symptoms 
                       “மார்பில் விைாவிரண்டில் மண்ணுனமிகு ந ரியில் 
      தசர்ந்து வலித்தல் திணறல் – தார்மூச்சு  
      உப்பல் வயிற்று லுருவது முற்குறியாச் 
      நசப்பிளரப்பு த ாய்க்குதளனத் ததர்” 
- யூகி ளவத்திய சிந்தாமணி(38)  
     Generally the prodromal symptoms and intensity of the disease will be recognised 
earlier by chronic asthmatics. While taking unsuitable food and while inhaling the chill 
air the patient develops rhinitis, sneezing, chest discomfort, chest tightness, pain, 
difficulty in normal breathing, pain in para vertebral region with dyspnoea, distension of 
abdomen and excess sweating. 
Types of Swasakasam 
                           Swasakasam (Iraippu) has been classified into 5 types. 
           Of  these, first  four  types  are based on kuttram and the final one is based on 
intensity of breath. They are as follows 
1. Vali Iraippu 
2. Iya Iraippu 
3. Iyavali Iraippu 
                                 4.   Mukkutra Iraippu 
                                 5.  Melnokku Iraippu 
Apart from this further it is also classified into another 5 types. 
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                  “சிறுதப றிளரப்பு திணறல் மந்தாரம் 
    வருதம லிளரப்புந் தின்மாண்பு” 
- யூகி ளவத்திய சிந்தாமணி 
      They are as follows 
 Sittru Iraippu 
 Per Iraippu 
 Thinaral Iraippu 
 Mandhara Iraippu 
 Mael Iraippu 
Signs and symptoms 
                “வன்ளமயாய் தகாளழகட்டி இருமி வழீும் 
                                   மா ாகம் தபாலதவ வாங்குஞ் சுவாசம் 
                     திண்ளமயாய்ச் தசருமுண்டா மடிக்க டிக்குஞ் 
               சீரண மிலாமதல வயிறு மூதும் 
                     ன்ளமயாய்  ாசியது தணல்தபா லாகும் 
                                  லிந்துடம்பு வற்றி வருங் குரலுங் கம்மும் 
                      உண்ளமயா யுண்ணாக் கிலூறுங் தகணி 
                                   யுழந்துதம சுவாசகா சத்தி நனாப்தப” 
- யூகி ளவத்திய சிந்தாமணி(38A) 
Vali iraippu noi 
              Vatha dosha gets aggravated due to ingestion of food that is not easily digested, 
wandering under hot sun rays, eating tubers. Due to increased vatha dosha the patient 
may feel condition as if nothing is inside the chest. Inspite of all these conditions patient 
doesn’t experience severe illness and this condition is curable. Vali iraippu is also 
mentioned as “Soothira swasam”. 
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Kabha swasam 
          Kapha swasam is caused due to increased kapha dosha because of taking foods  
which increase kapha and also roaming in chill air. It produces nasal congestion, rhinitis, 
chest tightness, inability to breathe. 
         Sometimes constricted type of chest pain may aggravate to the extent as if the patient 
dies of inability to breath. When the patient mildly attempts to cough and expectorates 
some mucus relief occurs for some extent. When the patient does not cough and expel the 
mucus dyspnoea occurs and patient is unable to lie on bed, makes him to stand. 
           Sweating on forehead, blackening of face, chillness of limbs, dryness of tongue, 
shivering of body, dyspnoea, inability to sleep are the associated symptoms of this   
disease. It is also known as “Thamaraga swasam”. 
 Iyavali iraippu 
           In this condition both kapha dhosam and vatha dhosam are dearranged together 
and causes the following symptoms. Symptoms of this type will be very severe and the 
derangement of vatha dosha combines along with udhana vaayu. 
           Clinical features of this type are dyspnoea, inability to inspirate and expirate air, 
constipation, abdominal distension, dryness of tongue, redness and painful eyes, 
shivering of body, giddiness, excessive sleep, incoherent talk, etc., this condition is also 
called as “Vichinna Swasam”. 
Mukkuttra iraippu 
          In this condition, all the three doshas gets deranged at once and udhana, abanan, 
viyanan, samanan get deranged one by one which in turn affects the seven major 
elements of the body. It is life threatening type of asthma. 
           The prodromal symptoms are Shivering of body, dyspnoea, depression, breathing 
like cow’s breathing, chest tightness and pain, constipation, oliguria, pain all over the 
body, stammering and excessive sweating over the forehead. This is also called as 
“Thinaral Iraippu”. 
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 Maelnokku Iraippu 
               If any of the above mentioned disease continues for many days without response 
to treatment, then the upward directional udhana vaayu loses its strength and in such a 
situation, expiration may not be possible. The patient tends to develop dyspnoea with 
prominent eyeball. There may be dryness of mouth. Patient may be unable to speak; he 
may appear astonished and will not lie down on the bed he may look upward he may also 
attempt to exhale by his opened mouth. If proper treatment is given at this stage he may 
survive. Otherwise he may fall unconscious with darkening of face and may die with 
mouth open
(38)
. 
Other factors affecting the disease 
 Eating foods which will induce excessive kapha.
 Exposure to chill air.
 Living in the mountains
 Walking in the cold climate.
Pulse 
                        “கபமல்லாது காச சுவாசம் வாராது” 
(39)
. 
 Kaba Nadi
 Vathakaba Nadi
 Kapha pitha Nadi are the classical pulse for Swasakasam.

Sputum 
 If the sputum is found excessive in quantity, light weight and foamy, it is 
considered that the disease gets developed due to Kapha dosham.
 If the sputum is black in colour, hard and with smell of flesh, it will denote Kapha 
dosham.
 If it is found white like pus and mixed with yellow colour, it will denote Pitha 
dosham.
(40)
. 
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3.4. MODERN ASPECT OF THE DISEASE 
BRONCHIAL ASTHMA 
Introduction 
           Asthma, the word was derived from Greek word. The term “ASTHMA” in Greek 
means breathless or breathe with open mouth. 
            Asthma is defined as a chronic inflammatory disorder of the airways, 
characterised by reversible airflow obstruction causing cough, wheeze, chest tightness 
and shortness of breath. Inflammation of the bronchial wall involving eosinophil, mast 
cells and lymphocytes, together with the cytokine and inflammatory products of these 
cells, induces hyper-responsiveness of the bronchi so that they narrow more readily in 
response to a wide range of stimuli. Narrowing of the airway in usually reversible, but in 
some patients with chronic asthma the bronchial wall inflammation may lead to 
irreversible obstruction of airflow. 
 Asthma is thought to be caused by a combination of genetic and environmental 
factors. Environmental factors include exposure to air pollution and allergens. Other 
potential triggers include medications such as aspirin and beta blockers. 
 Diagnosis is usually based on the pattern of symptoms, response to therapy over 
time, and spirometer. Asthma is classified according to the frequency of symptoms, 
forced expiratory flow rate. It may also be classified as atopic or non-atopic, where atopy 
refers to a predisposition toward developing a type 1 hypersensitivity reaction. 
Epidemiology 
            The prevalence of asthma increased steadily over the later part of the century first 
in the developed and then in the developing countries. Current estimates suggest that 
asthma affects 300 million people world-wide and additional 100 million persons will be 
diagnosed by 2025 In India,15-20 millions are asthmatics. About 2,50,000 annual deaths. 
 In 2015, 358 million people globally had asthma, up from 183 million in 1990.It 
caused about 397,100 deaths in 2015, most of which occurred in the developing world. It 
often begins in childhood. 
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            Epidemiological studies suggest that the multiple genetic and environmental 
factors contribute to the causation of asthma, a clinical condition that is viewed as a 
cluster of related disorders to smooth muscle hypertrophy. 
(41) 
Signs and symptoms 
 Asthma is characterized by recurrent episodes of wheezing, shortness of breath, 
chest tightness and coughing. Sputum may be produced from the lung by coughing but is 
often hard to bring up. During recovery from an attack, it may appear pus-like due to 
high levels of white blood cells called eosinophills. 
 Symptoms are usually worse at night and in the early morning or in response to 
exercise or cold air. Some people with asthma rarely experience symptoms, usually in 
response to triggers, whereas others may have marked reactivity and persistent 
symptoms. 
Associated condition 
 A number of other health conditions occur more frequenty in those with asthma, 
including gastro-esophageal reflux disease (GERD), rhinosinusitis and obstructive sleep 
apnea. Psychological disorders are also more common, with anxiety disorders occurring 
in between 16-52% and mood disorders in 14-41%. However, it is not know whether 
asthma causes psychological problems or psychological problems lead to asthma. Those 
with asthma, especially if it is poorly controlled, are at increased risk for radio contrast 
reactions. 
Causes of asthma 
 No single cause has been identified for asthma. Instead, researchers believe that 
the breathing condition is caused by a variety of factors. 
 These factors include: 
 Genetics: If a parent has asthma, Children more likely to develop it. 
 History of viral infections: People with a history of viral infections during 
childhood are more likely to develop the condition. 
 Hygiene hypothesis: This hypothesis proposes that babies aren’t exposed to 
enough bacteria in their early months and years. Therefore, their immune systems 
don’t become strong enough to fight off asthma and other conditions. 
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 Early allergen exposure: Frequent contact with possible allergens and irritants 
may increase your risk for developing asthma. 
 
Factors that triggers asthma
 
 Smoking 
 Infections like cold 
 Allergens such as food, pollens, dust mites and pet dander 
 Exercise 
 Air  pollution and toxins 
 Emotional stress and anxiety 
 Weather, especially extreme changes in temperature. 
 Drugs ( such as aspirin, NSAID and beta blockers) 
 Emotional stress and anxiety 
 Singing, laughing or crying 
 Perfumes and fragrances 
 Acid reflux 
 Allergens are the most causative factor for 50 to 70% for adults in asthma. In 
children under 3 years of age, viral infections (respiratory syncytial virus) are the most 
common trigger. After 3 years of age, the allergies also begin to play an increasing role 
as a trigger. After 20 years of age, occupational exposure to any toxic substances and 
allergens also can be important triggers 
            Dietary deficiency of antioxidants may predispose to development of asthma 
from childhood days 
(42)
. 
Types of bronchial asthma 
 As many different factors come together to cause asthma, there are many different 
types of the disease, separated by age and severity. 
 Adult and children share the same triggers for symptoms that set off an allergic 
response in the airways, including airbone pollutant, mold, mildew and cigarette smoke. 
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Types 
 Childhood asthma 
 Adult-onset asthma 
 Occupational asthma 
 Difficult to control and severe asthma 
 Seasonal asthma 
Childhood asthma 
Children are more likely to have an intermittent form of asthma that presents in 
severe attacks. 
Some children might experience daily symptoms, but the common characteristic 
among children with asthma is a heightened sensitivity to substances that cause allergy. 
 The Centers for Disease Control and prevention (CDC) advice that children 
experience more emergency visits and admissions for asthma than adults. 
Adult-onset asthma 
 Asthma in adults is often persistent and requires the daily management of flare-up 
and preventing symptoms. Asthma can begin at any age. 
 Allergies lead to at least 30% of adult presentations of asthma. Obesity is a strong 
risk factor for adult-onset asthma and women are more likely to develop the condition 
after the age of 20 years. 
 People over 65 years of age make up a large number of deaths from 
asthma. 
Occupational asthma 
 This  is  a  type  of  asthma  that occurs as a direct result of a job or profession. 
Symptoms will apparent after attending a particular workplace. Industries with regular 
association to occupational asthma include baking, laboratory work or manufacturing. 
Other symptoms might include a runny nose and red eyes 
Difficult to control and severe asthma 
 These types involve consistent, debilitating asthma symptoms and breathing 
difficulties. Around 12 % percent of people with asthma have difficult to control or 
severe asthma. 
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Seasonal asthma 
This type occurs in response to allergens that are only in the surrounding 
environment at certain times of year, such as cold air in the winter or pollen during hay 
fever season. 
People still have asthma for the rest of the year but do not experience symptoms. 
Pathology 
 Inhaled allergens stimulate sensory nerve endings called irritant receptors lying 
below the airway epithelium. 
 Stimulation of these irritant receptors causes parasympathetic nerves to release 
acetylcholine (ACh). When acetylcholine binds to M3 muscarinic receptors on 
airway smooth muscle, a series of events is initiated which results in an increase 
in intracellular calcium and smooth muscle contraction (broncho constriction or 
bronchospasm). 
 Some inflammatory mediators such as histamine can also increase intracellular 
calcium and cause bronchospasm.
 Inflammation of the airways is brought on the several factors like eosinophil, T-
lymphocytes (CD4+), macrophages, and mast cells infiltrate the bronchial wall.
 The epithelium is vacuolated and the ciliated cells desquamate. Several cellular 
factors play their roles in the inflammatory process.
 Neuropeptides such as bradykinins, substance P and neurotension are lead to 
broncho constriction and excessive secretion of mucous.
 Mast cells initiate the response on exposure to allergens, excessive osmatic 
changes and variations in temperature.
 Macrophages produce cytokines, which are either broncho constrictor or 
bronchodilator. Presence of eosinophil in the inflammatory exudate is 
characterics of asthma.
 Eosinophils are derived from bloodstream. Major basic proteins and cationic 
proteins of eosinophil lead to destruction of mucosal surface.
 T-lymphocytes, especially CD4+ produce cytokines IL-3,IL-4, IL-5 and GM-CSF 
which modify the inflammation.
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 TNF which is an inflammatory cytokine is expressed in greater amounts by mast 
cells. The bronco-alveolar secretions contain higher levels of TNF.
 Possibly platelet derived humeral factors also modify the inflammation.
 The main chemical transmitters, which alter the airways, are histamine, 
prostaglandin and leukotriene. These lead to contraction of bronchial muscle, 
increase in vascular permeability and excessive secretion of abnormal mucous. 
Airway inflammation persists for several years. Its severity correlates severity of 
asthma. Hyper responsiveness of the inflamed airways is aggravated by 
autonomic and neural mechanisms.
 The final result is obstruction of the small and medium sized airways brought 
about by mucosal oedema, tenacious mucous and broncho constriction. 
(43)

Classification 
               Bronchial asthma classified into 2 groups 
1.  Extrinsic asthma (Atopic) 
2.  Intrinsic asthma (Cryptogenic) 
 
 Extrinsic 
 IgE was raised at least 70%
 Atopic subjects
 Onset was early (10-15 years)
 Intermittent in nature
 Family history of atrophy
Intrinsic 
 IgE was normal or low 
 Usually Non-atopic subjects 
 Onset in middle age (30years)
 Constant in nature
 Family history of asthma.
(44)
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Clinical Features 
  Asthma classically displays a diurnal pattern, with symptoms and lung function 
being worse in early morning. 
              Typical symptoms are 
 Recurrent episodes of wheeze
 Chest tightness
 Breathlessness
 Sometimes Cough
 Cough may be a dominant symptom in some asthmatic patients and the lack of 
wheeze or breathlessness may lead to a delay in reaching the diagnosis of called “cough 
variant asthma”. 
         The classical aspirin-sensitive patient is female and presents in middle age with 
asthma, rhino-sinusitis and nasal polyps. Aspirin sensitive patients may also report 
symptoms following alcohol (white wine) and foods containing salicylates. 
Diagnosis 
 Diagnosis of bronchial asthma is clinical. The history of sudden attack of 
paroxysmal dyspnoea, cough and auscultator hallmark of expiratory wheeze 
heard all over the chest are diagnostic.
 Long duration of complaints history of allergy and positive family history are 
other helpful clinical points.
 Objective assessment of the severity of airways obstruction and response to 
broncho dilator therapy can be made by use of bedside peak flow meter.
 Respiratory function tests reveal gross reduction in FEV1, FEV1/FVC ratio and 
PEFR and increase in the time taken for forced expiration.
 It is important to assess the severity of airways obstruction. Confirmation of the 
diagnosis of asthma is usually achieved by serial PEFR monitoring. PEFR in the 
majority of cases shows a diurnal variation of more than 15 % and improvement 
with therapy.
 When it is necessary to investigate for provocative factors bronchial challenge 
testing or BPT may be desirable.

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Clinical features which indicate severe ventilator impairment are 
1. Inability to narrate history continuously or severe distress even on mild    
exertion 
                2. Cyanosis, flapping tremors 
                3. Mental confusion 
                4. Respiratory rate above 25/min 
                5. Heart rate persistently above 110/min 
                6. Inspiratory fall in blood pressure exceeds 16 mm Hg 
                7. PEFR less than 40 % of predicted value 
                8. Feeble breath sounds 
Differential diagnosis 
 Chronic bronchitis
 Cardiac failure
 Pulmonary embolism
 Pulmonary eosinophilia
 Metabolic acidosis
 Emphysema
 Foreign body aspiration.
(45)

Management of asthma 
 In addition to using maintenance medications, their are some steps to make  
healthier and reduce your risk for asthma attacks. These include: 
 Eating a healthy diet: 
 Eating a healthy, balanced diet can improve  overall health, which may 
reduce the risks for asthma attacks. In that same vein, research suggests that 
eliminating processed foods may cut down on the risk of  asthma attack. 
 Quitting smoking: 
 Irritants such as cigarette smoke can trigger asthma and it also put yourself 
at greater risk for COPD. 
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 Exercising regularly: 
 Activity can trigger an asthma attack, but regular exercise may actually 
reduce the risk of breathing problems. Aerobic activity can strengthen the lungs 
and helps to breath better. 
 Managing stress: 
 Stess can be a trigger for asthma symptoms, Stress can also make stopping 
an asthma attack more difficult. Find healthy ways to reduce the stress and 
anxiety. 
PHARMACEUTICAL REVIEW 
CHOORANAM 
Definition 
                   Chooranam are fine dry powder of drugs. The term “Chooranam” may be 
applied to the powder of a single drug or a mixture of two or more drugs, which are 
powdered separately prior to their being mixed to homogeneity. 
Method of preparation 
Equipment required 
 The drug enumerated in the recipe in clean and dried state. 
 A mortar and pestle. 
 A fine sieve or fine cloth of close mesh. 
Process of preparation: 
 The drugs which are to be used in the preparation should be taken from recently 
collected material. Drugs which are aged by prolonged storage or changed in 
colour, taste and scent and those that are insects infected or attacked by fungi 
should be positively rejected. 
 The raw drugs are chopped and dried in sun or shade completely and the drugs are 
pounded in stone morter then sieved through a fine mesh. 
 If the raw drugs are pounded together it will not yield a beneficial result. 
 Some substances before pounding are roasted. The substances to be roasted are 
kept in an earthen ware and under minimal heat separately. In case if the  different 
substances to be roasted together, some drugs are roasted earlier and some are 
burnt under the same heat. So they should not be roasted together. 
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 In general, the aromatic drugs are slightly fried in order to enhance their aroma 
and milling properties. Any extraneous material, organic or inorganic, should be 
removed from the drugs by close inspection. 
 The Chooranam should be as fine as to be called amorphous and should be  never 
damp. The fitness of the sieve should be 100 mesh or still finer. 
Purification of the prepared Chooranam 
             “தாநனன்ற சூரணத்தின் சுத்திக்தகளு 
       தப்பாதத சரக்நகல்லாஞ் சூரணித்து 
        ாநனன்ற வாவின் பாலாற் பிளசந்து 
        லமான சட்டியிதல பாளலவிட்டு  
       வாநனன்ற சுத்தசலம் பாதிவிட்டு  
       வைமாக தமற்சீளல தகாடு கட்டிப் 
       பாநனன்ற சூரணத்ளதப் பிட்டுதபால் ளவத்து 
       பதறாதத நவந்நதடுக்கச் சித்தியதம.” 
- அகத்தியர் ளவத்திய இரத்தினச் சுருக்கம்  
                  The prepared Chooranam is mixed with the milk in a pot half a quantity milk 
and half a quantity water is taken. 
                  The mouth of the pot is covered with a thin cloth material. Above this cloth 
the mixed Chooranam is placed. The pot is covered with lid and heated. 
                   “ஆமப்பா ரவியுலர்த்திப் நபாடிதான் நசய்து 
          அப்பதன சமனாய்ச் சர்க்களரளயச்தசர்த்து 
           ாமப்பா நகாண்டு வர ததாஷம் தபாச்சு  
           ன்றாகச் சுத்தி நசய்யாச் சூரணந்தான் 
          தாமப்பா தராகத்ளத நவல்லா தப்பா 
          தைமான வியாதி நயல்லாம் பாரிக்கும் பார் 
          தவமப்பா சுத்தி நசய்து நகாண்டாயானால் 
          நவகுசுறுக்காய் தீருமா வியாதி தகளு”. 
- அகத்தியர் ளவத்திய இரத்தினச் சுருக்கம்(46) 
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       Then the Chooranam is dried in the sunlight and powdered. Equal amount of 
sugar is added and taken internally. Many types of disease get cured. If the drug is taken 
without purification the diseases does not cure. If taken after purification the disease gets 
cured easily. 
Storage 
               The prepared Chooranam should be allowed to cool by spreading and mixing, 
prior to packing. They should be stored in tightly stoppered glass, polythene or tin 
containers or cellophane bags and sealed. These bags should in turn be enclosed in card 
board boxes. 
              The Chooranam to facilitate easy handling and to assure exact dosage of 
administration could be pressed into tablets with the addition of a suitable binder. These 
tablets could be packed in bottles or tubes made either of glass or packed in strip of metal 
foil or plastic sheets. 
 Shelf life of medicines 
                 Medicines can be classified into internal and external medicines .They are each 
in 32 types. Chooranam comes under the category of internal medicines. The shelf life of 
medicines indicates the potency of medicines. The medicine even though seems to be 
fresh is not efficacious after sometime. So the medicines should not use after certain 
period. 
             As per siddha literature Agamarunthu padal in Gunapadam Thathu-seevam text 
                                 உயர்சூர ணம்பிட்டு வடகம் நவண் நணய் ான்கி 
                       னுயிர்மூன்று திங்கைாகும்(47) 
   From the above quote, the shelf life of Chooranam (powder) is 3 months. But 
According to AYUSH guidelines the shelf life of Chooranam (powder) is 1 year 
(48)
.              
The Chooranam is said to retain its potency for three months and then gradually 
deteriorate. However, if properly packed and stored they keep good for a year as per 
AYUSH guidelines. 
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ANALYTICAL SPECIFICATIONS OF CURNA/ CHOORNAM 
S.NO     TESTS 
     1. 
 
     2. 
     3. 
     4. 
     5. 
     6. 
     7. 
 
     8. 
 
     9. 
 
 
 
 
 
    10. 
 
 
 
 
     11. 
       
 
 
     
     
 
     12. 
 
 
     
 
 
     13. 
Description 
Macroscopic, Microscopic 
Loss on drying at 105
0
c 
Total - ash 
Acid – insoluble ash 
Water- soluble extractive 
Alcohol- soluble extractive 
Particle size (80-100 mesh for churna; 40-60 mesh for  
kvatha churna) 
Identifications, TLC/HPLC- with marker (wherever 
possible) 
Test for heavy/ Toxic metals 
       Lead 
       Cadmium 
       Mercury 
       Arsenic 
Microbial contamination 
       Total bacterial count 
       Total fungal count 
 Test for specific pathogen 
       E. coli 
       Salmonella spp. 
       S. aureus 
       Pseudomonus aeruginosa 
Pesticide residue 
      Organochlorine pesticides 
      Organophosphorus pesticides 
      Pyrethroids 
Test for Aflatoxins(B1, B2, G1, G2) 
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3.6. PHARMACOLOGICAL REVIEW 
A. REVIEW OF DRUG (Modern Medicine) 
BRONCHODILATOR DRUGS USED 
 A bronchodilator is a substance that dilates the bronchi and bronchioles, 
decreasing resistance in the respiratory airway and increasing airflow to the lungs. 
 Bronchodilators may be endogenous (originating naturally within the body), or 
they may be medications administered for the treatment of breathing difficulties. 
 They are most useful in obstructive lung disease of which asthma and COPD are 
the most common conditions.
Types of bronchodilator drugs 
              Bronchodilators are either short-acting or long acting. Short-acting 
bronchodilators  are predominantly used as preventers. 
               There are three types of bronchodilators namely 
                       1. β2-agonists (short and long-acting) 
                       2. Anticholinergic (short and long- acting) 
                       3. Theophylline (long-acting) 
1.β2-agonists 
(a) Short-acting β2-agonists 
 This medication is providing quick or “rescue” relief from acute 
bronchoconstriction.
 These medications usually take effect within 20 minutes or less, and can last from 
4 to 6 hours.
 These inhaled medications are best for treating sudden and severe or new asthma 
symptoms.
 Taken 15 to 20 minutes ahead of time, these medications can also prevent asthma 
symptoms triggered by exercise or exposure to cold air.

Examples:
        Salbutamol, Levosalbutamol, Pributerol, Terbutaline, Epinephrine, Ephedrine. 
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(b)Long –acting β2- agonists 
 These are long term medications taken routinely in order to control and prevent 
broncho constriction.
 These medications may take longer to begin working, but relief airway 
construction for up to 12 hours.
 Commonly taken twice a day with an anti-inflammatory medication, they 
maintain open airways and prevent asthma symptoms, particularly at night.

Examples:
Salmeterol, Fenoterol, Pirbuterol, Clebuterol, Formoterol, Bambuterol, 
Indacaterol 
(49)
 
(2)Anticholinergics
 
 Anti cholinergics or Anti muscarinic drugs relax the smooth muscles but response 
is slower than Beta-2 agonist.
 Some examples of anticholinergics are Tiotropium bromide and Ipratropium 
bromide.
 Tiotropium bromide is long acting, a single inhalation can have effect lasting for 
24 hours. It reduces the frequency and severity of episodes.
 Ipratropium bromide is short acting, given by inhalation which has effect for 4-6 
hours.

Theophylline 
 Theophylline is long acting bronchodilator that prevents asthma episodes.
 Available in oral and injectable form.
 It is prescribed in severe cases of Asthma or those that are difficult to control.

 Blood tests are required to monitor therapy and to indicate when dosage 
adjustment is necessary 
(50)
.
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MECHANISM OF ACTION OF BRONCHODILATOR DRUGS 
 Beta-2 agonist drugs bind to beta-2 receptors on airway smooth muscle   
relaxation. When airway smooth muscle relaxes, the diameter of the air passages 
is enlarged. 
 Bronchodilator drugs blocks the action of phosphordiesterases and prevents the 
breakdown of cAMP to 5-AMP. This also has the effect to relaxing smooth 
muscle and allowing the airways to dilate.
 The bronchoconstriction effects of acetylcholine can be blocked by muscarinic 
antagonists. Muscarinic antagonists bind to muscarinic receptors and 
preventacetylcholine from binding.
 Bronchodilator can also be achieved by alpha-2 agonist drugs that bind to alpha 2 
receptors on parasympathetic nerves and prevent acetylcholine from being 
released
(51)
. 
B. PHARMACOLOGICAL STUDY IN ANIMAL MODELS 
BRONCHODILATOR ACTIVITY 
 In vitro methods 
 Spasmolytic activity on guinea pigs isolated tracheal chain 
The isolated tracheal chain of guinea pigs can be used for testing compounds 
which inhibit bronchospasm. It detects sympathomimetic, H1-histamine receptor 
antagonist properties of test drug. 
 Methodology 
              Guinea pig of either sex weighing between 300-500 g are sacrificed using ether 
anaesthesia. The entire trachea is dissected out and cut into individual rings. Twelve to 
fifteenrings are tied together with silk threads and mounted in the organ bath containing 
Krebs-Henseleit solution and maintained at 37
o
C, under a tension of  0.5 g and gassed 
with carbon. Isometric contractions are recovered via a strain gauge  transducer on a 
polygraph. Forty five minutes are allowed for equilibration before the addition of the 
spasmogen. The following spasmogens used Histamine, Carbachol, LTC4 or LTD4. It 
takes about 10-12 min for reaching the contraction to a maximum. At this stage, standard 
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and test drugs are administered. The bronchial response is  allowed to plateau and 
recorded. The tissue is rinsed thoroughly and the control  contractions are induced again 
by adding spasmogen. The percent  of  inhibition of spasmogen induced contractions is 
calculated. From dose response curve ED50 is  calculated. 
(52)
 
 Isolated Frog Rectus Abdominis Muscle Preparation
 
                A frog is pithed and laid out on frog dissection board. The skin of the anterior 
abdominal wall is cut by a midline incision which is extended laterally up to the anterior 
aspects of the limbs. This exposes the flat whitish muscle of the anterior abdominal wall 
from their pubic origin to their sternal insertion. The two recti are removed and placed in 
frog ringer solution in a shallow dish. They are carefully cleaned and one of them is 
trimmed to the desired size and mounted in an organ bath of 5ml capacity, at room 
temperature and aerated with oxygen. For recording purposes, an isotonic lever with a 
sideways writing point is used tangential to the smoked drum, balanced for a tension of 
2.5gm with an extra load of 1gm on the long arm. A standard solution of Acetylcholine is 
added to the bath and a slow contraction is recorded on the slow moving drum for exactly 
90sec. The drum is stopped and the bath fluid is replaced by fresh Frog-Ringer. An extra 
1gm load is used to extend the muscle to its original length. 
(53)
. 
In vivo methods
 
Histamine induced bronchospasm in guinea pig 
                  Guinea pigs subjected to inhibition of aerosols containing histamine or other 
bronchospasm inducing agents, exhibits the symptoms of asphyxiating convulsions 
resembling acute attack of bronchial asthma. These challenging agents are administered 
in the form of aerosols through a nebulizer to individual guinea pigs placed in a 
histamine chamber. The initial symptoms are increased frequency of breathing, forced 
breathing and finally asphyxiating convulsions. The occurrence of these symptoms can 
be delayed by antagonistic drugs and bronchodilators. Pre-convulsion time is noted as the 
end point. 
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Methodology 
                Male guinea pigs weighing around 400 grams are used in groups of 8-10 
animals. The animals are treated with test / standard drugs orally or subcutaneously. The 
animals are then placed in the standard Histamine chamber, 30 minutes after the 
administration of drug and exposed to an aerosol of 0.1 % solution of histamine 
dihydrochloride through a nebulizer. Time required for the onset of asphyxiating 
convulsions is recorded. The animal is immediately withdrawn from the inhalation box 
and placed in a well-ventilated area for revival from the convulsions. This method has 
been further improvised using an ultra-sound nebulizer which provides the steady 
exposure to histamine solution at a pre-determined rate. Percentage  increase of pre-
convulsion time is calculated from the average values of treated and control groups of 
guinea pigs. ED50 values denoting 50% increase in the pre-convulsion time can also be 
calculated. Histamine aerosol exposure is a very commonly used and dependable method 
for screening the bronchodilator activity of novel compound.
(54) 
Egg albumin induced anaphylaxis in guinea pig 
                Guinea pig was sensitized by two intra peritoneal injections of 0.5 ml and 10% 
w/v solution of egg albumin at a 48 hours interval. After sensitization, the animals were 
divided into two groups. Animals of group I received 0.5% CMC and serve as control 
group. Animals of group II received ethanolic extract trial drug (500 mg/kg. once daily) 
dissolved in distilled water for 14 days. On day 14, two hours after treatment, the animals 
were challenged with 0.5 ml of 2% w/v solution of egg albumin into the saphenous vein. 
Guinea pigs were observed for onset of symptoms such as dyspnoea and cyanosis, 
duration of persistence of symptoms and mortality 
(55)
. 
 
ANTI- HISTAMINE ACTIVITY 
Effects of diphenhydramine in experimentally produced asthma in guinea pigs 
Aim 
            To demonstrate the antagonistic effects of diphenhydramine against histamine 
induced bronchospasm in the guinea pig. 
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Principle 
             difficulty in breathing and convulsion. These effects of histamine are mediated 
through the action of histamine on H1 receptors. Diphenhydramine is a H1 receptors 
blocker. Therefore, diphenhydramine prevents the bronchospasm induced by histamine. 
Guinea pig is very sensitive to histamine. When guinea pig is exposed to histamine 
vapour it exhibits bronchospasm.            
Equipments and other materials required 
              Histometer, stop watch, disposable needle and syringes. 
Animal : Guinea pigs  
Drug solutions required 
 Normal saline 
 Diphenhydramine 5 mg/ml 
 Histamine diphosphate 30µg/ml 
 
Procedure 
            Select 4 guinea pigs having body weight between 250-350 grams. Fast the guinea 
pigs for 12 hours before the experiment. Divide the guinea pigs into 2 groups of 2 
animals each. Weigh the guinea pigs in each group and mark them for identification. 
Administer the drug solutions as Group I Normal saline 1 ml/kg, Group I 
Diphenhydramine 5 mg/kg. After one hour place each guinea pig in histamine chamber 
and replace the cover. With the help of compressor, spray a finely atomized mist of 
histamine diphosphate from nebulizer in both comparments. Using a stop watch, record 
the time of histamine administration. Observe the signs of respiratory distress and the 
animal falling on its side and record the observations 
(56)
. 
Isolated Guinea Pig Ileum 
Overnight fasted guinea pigs of either sex weighing 400-600gram were sacrificed 
using cervical dislocation method. The lower most 10cm of ileum was removed from the 
abdomen and placed in a shallow dish containing warm Triode solution. Ileum lumen was 
cleaned by passing through warm 0.9% saline and then segments about one inch in 
REVIEW OF LITERATURE 
 
BRONCHODILATOR ACTIVITY OF KANDANKATHARI CHOORANAM Page 50 
 
length, were made. The mesenteric attachment and blood etc. were carefully cleaned and 
tissues was mounted in a thermostatically controlled Dale’s organ bath containing 20ml 
Triode’s solution under basal tension of 500mg. the composition of solution in was Nacl, 
137; Cacl2, 1.8; Kcl, 2.7; glucose, 5.55; NaHco3, 11.9; Mgcl2, 1; NaH2Po4, 0.4. The 
solution was continuously bubbled with air. The responses to drug were recorded on a 
student physiography using isotonic transducer, which exerted a basal tension equivalent 
to 500mg load tissue. The issue was allowed to equilibrate for 30 min, during which, the 
bathing solution was changed at every 10 min. Increasing concentration of histamine 
were added to the bath and the control cumulative concentration-response curve was 
constructed 
(57)
. 
 
C. REVIEW OF SIDDHA DRUGS 
             List of some Siddha drugs used in Bronchial Asthma 
 Swasakudoori Mathirai
(58)

 Vasantha Kushmagaram
(58A)

 Gowri Chinthamani Chendhooram
(58B)

 Thalisadi Chooranam
(59)

 Pavala Parpam
(58C)

 Kashthoori Karuppu
(58D)

 Adathodai Chooranam
(60A)

 Swasakasa Matthirai
(60B)

 Kodasoori Kuligai
(58E)

 Milagu Chooranam
(61)

 Thalaga karuppu
(58F)

 Karpooradhi Chooranam
(62)

 Swasakrudhum
(62A)

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 Sivanar Amirtham 
(58G)

 Thooduvalai nei
(58H)

 Mahathalisapatthira Chooranam
(63)

 Arakku thailam
(58I)

 Soombu theneer
(58J)

 Adhatodai kudineer
(58K)

 Nochi Thailam
(58L)

D. LATERAL RESEARCH 
Solanum xanthocarpum:
Hypoglycemic activity of Solanum xanthocarpum 
(64) 
                The aqueous extract showed significant hypoglycemic effect in both normal 
and streptozotocin induced diabetic rate at dose of 100 and 200mg/kg. The avtivity 
showed by aqueous extract was comparable to that of standard oral hypoglycemic agent 
glibenclamide. The experimental result indicated that it exhibited a potent blood glucose 
lowering property both in normal and streptozotocin induced diabetic rats. The LD50 of 
the extract was found tobe high indicating high margin of safety. 
Antifilarial activity of Solanum xanthocarpum 
               Latin Mohan et al. reported the larvicidal potential of crude extracts of Solanum 
xanthocarpum  and  suggested  its  suitability  as  an ecofriendly, effective larvicide in the 
management of mosquito populations and in limiting the outbreak of various vector borne 
epidemics. 
Hepatoprotective activity of Solanum xanthocarpum 
(65) 
              In Chandana VR et al. investigation, Solanum xanthocarpum extracts was 
evaluated for hapatoprotective activity using CCL4 induced hepatotoxicity in rats. The 
hepatotoxicity induced by CCL4 is due treated with Solanum xanthocarpum extracts 
showed significant increased in the level of enzyme which indicates the antioxidant 
activity of Solanum xanthocarpum. Jigrineis polypharmaceutical herbal formulation 
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containing aqueous extracts of 14 medicinal plants including Solanum xanthocarpum and 
used for liver ailments. 
Anti-Fertility activity of Solanum xanthocarpum 
(66) 
                Solasodine, an alkaloid of solanum xanthocarpum possesses antispermatogenic 
activity. In Dixit VP 1980 study, chronic administration of solasodine (20mg/ kg each 
other day oral for 60 days) rendered male rats and dogs infertile. Mating test showed 87% 
infertility in rats, this returned to normal after 60 days cessation of drug feeding. 
Solasodine is well tolerated and inhibits spermatogenesis and sperm motility. No 
significant change was noticed in the weight of testes and accessory sex organs. The 
RNA, protein, salicylic acid and glycogen contents of the test were reduced significantly, 
serum proteins, triglycerides, Serum enzymes (GOT/GPT / Alkaline phosphatase) 
nonesterified fatty acids levels were in normal range. Solasodine is estrogen free but 
inhibits testosterone release from dispersed mouse Leydig cells (200 Um release). 
Solasodine can be developed as male pill of plant origin. 
 
Piper longum: 
Immunomodulatory and Anti-tumor activity of Piper longum 
                  Alcoholic extracts of the fruits was 100% toxic at a concentration of 500 
micro/ml to Dalton’s lymphoma ascites (DLA) cells and 250 micro/ml to Ehrlich ascites 
carcinoma (EAC) cells. Piperin was found to be cytotoxic towards DLA and EAC cells at 
a concentration of 250 micro/ml. Alcoholic extracts and piperin  was also found to 
produce cytotoxicity towards L929 cells in culture at a concentration of 100 and 50 
mico/ml, respectively 
(67)
 
Anti-hyperglycemic activity of Piper longum 
                  The aqueous and methanolic extracts of piper longum root produced 
significant anti-hyperglycemic activity at a dosage of 200mg/kg b.w in diabetic treated 
rats. 
Antimicrobial activity of piper longum 
                  Various extracts of  Piper longum were prepared and evaluated against 
bacterial pathogens, such as Salmonella albus typhi, Pseudomonas aeruginosa, 
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Escherichia coli and Bacillus megaterium and one fungus, Aspergillus.niger. Compared 
to streptomycin all the extracts exhibited a good antibacterial activity. The isolated 
constituents and n-hexane extract were found to show varying degree of    antibacterial 
activity against all the tested bacteria. However the aqueous extract did not show 
antibacterial activity against the tested bacteria 
(68)
. 
 
Piper nigrum: 
Anti-inflammatory activity and Anti-Rheumatic activity of piper nigrum 
             Piperin has anti-rheumatic effects in animal models and anti-inflammatory effects  
on  IL1β-stimulated FLSs. Piperin also inhibited the activation of the transcription factor 
AP-1, but not NFκB, in our system. 
Antibacterial activity of Piper nigrum 
             The acetone extract of black pepper displayed excellent inhibition on the growth 
of Gram positive bacteria. Staphylococcus was susceptible followed by Bacillus and 
Streptococcus. The MIC values are 125, 250 and 500 ppm, respectively. Among the 
Gram negative bacteria Pseudomonas was more susceptible to black pepper followed by 
E.coli, klebsiella and salmonella 
(69)
. 
   
Zingiber officinale: 
Antimicrobial activity of Zingiber officinale 
 Ingenol and [6]- shogaol, isolated from ginger rhizome, demonstrated antiviral 
activity.32 [10]-gingerol has been reported as active inhibitor of Micobacterium avium 
and Micobacterium  tuberculosis in vitro. Gingerol and related compounds have been 
investigated for antimicrobial activities. [6]- gingerol and [12]- gingerol, isolated from 
ginger rhizome, demonstrated antibacterial activity against periodonatal bacteria. 
Antinociceptive activity of Zingiber officinale.  
 [6]-shogaol has produced anti-nociception and inhibited the release of 
substance p in rats, seemingly via the same receptor to which capsaicin binds. However, 
it was observed to be 100 times less potent and to elicit half the maximal effect of 
capsicin. 
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Toddalia asiatica  
Antibacterial activity of Toddalia asiatica 
                 In vitro antibacterial activities of different plant extracts were tested against 
various clinically important microbial pathogens of  Enterobacter faecalis, proteus 
vulgarisand serratia marcescens procured from the department of microbiology, RVS 
College of arts  and science, Coimbatore and were maintained on nutrient agar slants. 
0.2ml of overnight grown cultures of each organism was dispensed into 20ml of sterile 
nutrient broth and incubated for 3-5 hrs at 37
0 
C to standardize the culture to 10
6 
CFU/ml8. 10µ plant extract (40mg/0.1ml) was soaked by sterile filter paper discs were 
impregnated with plant extract placed on the surface of the medium and incubated at 
37
0
C for 24 hrs. The assessment of antibacterial activity was measured around the disc 
(70)
. 
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                               4. MATERIALS AND METHODS 
           In this dissertation “Kandankathari Chooranam” was taken as a trail drug from 
the Siddha literature “Akathiyar Attvanai Vagadam” - First Edition, page no: 63, 
Published by Dr.S.Arangarasan, Saraswathi Mahal Library,Thanjavur. 
Ingredients of the drugs: 
                 1.  Kandankathari Root (Solanum xanthocarpum) - 43gm  
                 2.  Araikeerai (Amaranthus dubius)                        - 85gm 
                 3.  Chukku (Zingiber officinale)                             - 255gm 
                 4.  Thippili (Piper longum)                                     - 255gm 
                 5.  Milagu (Piper nigrum)                                      - 255gm 
                 6.  Milagaranai pattai (Toddalia asiatica)                 - 85gm 
Associated drugs 
                 7.  Sugar ( Saccharum officinarum)                                 - QS                                                                                                                        
                  8.  Ghee                                                                       - QS 
Collection of the raw material 
  All the raw materials were bought from Ramasamy chetty country drug store, 
Parry’s corner, Chennai. 
Identification and Authentication of the drug 
          All the raw materials were identified and authenticated by the experts of 
Gunapadam. Government Siddha Medical College, Arumbakkam, Chennai-106. The 
specimen sample of all the raw drugs have been preserved in PG Gunapadam department 
individually for future reference. 
 
4.1. PREPARATION OF THE DRUG 
Purification of the drug  
           Purification Process for all the drugs mentioned here were done as per various 
classical Siddha literatures 
(71)
. 
       Kandankathari Ver    : The root was cleaned with white cloth. Finally washed                   
and dried 
         Araikeerai                      : Leave were washed in running water and finally dried. 
         Chukku                           : Skin of dried ginger was peeled off. 
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         Thippili                          :  Soked in 250 ml of lemon juice and it was dried. 
Milagu                          : Soked in 250ml of buttermilk for 3 hours and                                                       
Dried. 
        Milakaranai vaerpattai    :  Dust and odd materials were removed. 
 Preparation of the drug 
 Procedure 
       The purified ingredients were Pounded separately until it turns to a fine powder. 
Then the powder was sieved through a white cloth and all the powders were mixed well. 
The Chooranam was slightly roasted by adding ghee and sugar. The prepared 
Chooranam was kept in an air tight container and was lableled as “Kandankathari 
Chooranam” (KKC). 
 
Purification of the Chooranam: 
Pittaviyal murai (Milk Steaming process): 
The Kandankathari Chooranam was purified by Pittaviyal method (milk steam 
cooking) as per Siddha classical literature. A mud pot was taken and it was quarter filled 
by milk and quarter filled by water. The mouth of the pot was sealed by a cloth. This 
Chooranam was then placed over the cloth and the pot was covered with lid and heated. 
The same drug was later dried,  powdered then sieved again. It was used for the further 
study 
(73)
. 
Preservation of the drug 
                The prepared test drug was stored in a clean, air tight glass container. 
Administration of the drug 
          Form of the medicine  :       Chooranam (powder) 
          Route of administration         :        Enteral 
          Dose                                       :        Pakkalavu (6.022gm) 
          Vehicle                                   :        Hot water  
          Indications                               :       Swasa kasam (Bronchial Asthma) 
                                                                     Irumal (Cough) 
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INGREDIENTS OF KANDANKATHARI CHOORANAM: 
 
                                                                                  
 
 
 
 
 
 
 
 
 
 
 Fig no 1.1: Kandankathari                                             Fig no 1.2 : Araikeerai 
 (Solanum xandhocarpum)                                               (Amaranthus tristis) 
 
 
 
 
 
  
 
 
 
 
 
 
 
            Fig no 1.3: Chukku                                        Fig no 1.4: Thippili 
         (Zingiber officinale)                                                         (Piper longum) 
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            Fig.1.5: Milagu                                                Fig.1.6: Milagaranai vaerpattai 
            (Piper nigrum)                                                             (Toddalia asiatica) 
 
 
 
 
 
 
  
 
 
 
 
 
 
                 
     Fig.1.7. Ghee                                                                            Fig.1.8. Sugar 
                                                                                                (Saccharum officinarum) 
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                          Fig. 1.9.  Preparation of the Kandankathari Chooranam 
 
 
 
 
 
                        
                                      
 
 
 
 
 
                                                 Fig.2. Kandankathari Chooranam 
 
4.2. STANDARDIZATION OF THE DRUG 
            Standardization of the drug brings the validation of a medicine by subjecting the 
drug to many analysis and determining its quality and effectiveness. Standardization 
includes many studies such as its organoleptic properties, physical characteristics and 
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phytochemical properties and also to assess the active principles and elements present in 
the drug. 
Method of standardization: 
Techniques Involved In Standardization of Compound Drugs: 
 Macroscopic Methods
 Microscopic Methods
 Physical Methods
 Chemical Methods
 Biological Methods 
 
4.2.1. ORGANOLEPTIC CHARACTER: 
                  The organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its colour, odor, taste, texture etc. 
Colour: 
             A sample of Chooranam were taken in watch glasses and placed against white 
back ground in white tube light. The Chooranam were observed for its color by naked 
eye. 
Odour: 
            Chooranam were smelled, the time intermission between two smelling was kept 2 
minutes to nullify the effect of previous smelling. 
Taste: 
            A sample of  Chooranam was tasted and the taste was reported. 
Size: 
            The Chooranam was completely sieved through mesh size 88. 
 
4.2.2 PHYSICOCHEMICAL ANALYSIS:
(74)
 
          Physicochemical‐ studies of the trial drug have been done according to WHO 
Guidelines. Physico chemical studies like total ash, water soluble ash, acid Insoluble 
ash, water and alcohol soluble extract, loss on drying at 105°C and pH were done at, 
The Tamilnadu Dr. MGR Medical University, Chennai. 
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1. Solubility Test: 
     A pinch of sample (KKC) was taken in a dry test tube and to it 2 ml of the solvent 
was added and shaken well for about a minute and the results are observed. The test was 
done for solvents like distilled water, Ethanol, Chloroform and Ethyl alcohol the results 
are observed individually. 
2. pH value: 
                         Potentiometrically, pH value is determined by a glass electrode and a suitable pH 
meter. The pH of the Kandankathari Chooranam was written in results column. 
3. Loss on Drying: 
      An accurately weighed 1gram of Kandankathari Chooranam was taken in a 
tarred glass bottle. The crude drug was heated 105
0
 c for 6 hours in an oven till a constant 
weight. The percentage moisture content of the sample was calculated with reference to 
the shade dried material. 
4. Determination of total Ash: 
    Weighed accurately 2grams of Kandankathari Chooranam was added in crucible 
at a temperature 600
0
C in a muffle furnace till carbon free ash was obtained. It was 
calculated with reference to the air dried drug. 
5. Determination of acid insoluble ash: 
     Ash above obtained was boiled 5 minutes with 25ml of 1M Hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was washed 
with hot water and filter paper was burnt to a constant weight in a muffle furnace. The 
percentage of acid insoluble ash was calculated with reference to the air dried drug. 
6. Determination of water soluble ash: 
      Total Ash 1gram was boiled for 5 minutes with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with water and ignited for 15 minutes at 
a temperature not exceeding 450
0
c in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate. 
7. Determination of water soluble extractive: 
      4grams of air dried drug, Coarsely powered Kandankathari Chooranam was 
macerated with 80ml of distilled water in a closed flask for twenty-four hours, shaking 
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frequently. The solution was filtered and 25 ml of filtered was evaporated in a tarred flat 
bottom shallow dish, further dried at 100
0
c and weighted. The percentage of water 
soluble extractive was calculated with reference to the air dried drugs. 
8. Determination of alcohol soluble extractive: 
        1gram of air dried drugs; coarsely powdered Kandankathari Chooranam was 
macerated with 20ml alcohol in closed flask for 24 hours. With frequent shaking, it was 
filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was evaporated 
in a tarred flat bottom shallow dish, dried at 100
0
c and weighed. The percentage of 
alcohol soluble extractive was calculated with reference to air dried drug. 
 
4.2.3. PHYTOCHEMICAL ANALYSIS: 
                   The preliminary phytochemical screening test was carried out for each extracts 
of Kandankathiri Chooranam as per the standard procedure
 (74)
. 
1. Detection of Alkaloids:
Extracts were dissolved in dilute hydrochloric acid and filtered. 
a) Dragendroff’s test: Filtrates were treated with Dragendroff’s reagent (solution 
of Potassium with Bismuth iodide). Formation of red precipitate indicates the 
presence of alkaloids. 
2. Detection of Carbohydrates: 
Extracts were dissolved individually in 5ml distilled water and filtered. The filtrates 
were used to test the presence of carbohydrates. 
a)  Molisch’s test: To 2ml of a sample extract, two drops of  alcoholic solution of 
alpha naphthol are added. The mixture is shaken well and few drops of 
concentrated sulphuric acid is added slowly along the sides of the test tube. A 
violet ring indicates the presence of carbohydrates. 
3. Detection of Glycosides:
           Extracts were hydrolyzed with dilute HCl and then subjected to the test of 
glycosides. 
a) Cardiac glycoside (keller-killiani test): Extract was shaken with distilled water 
(5ml). To this, glacial acetic acid (2ml) containing few drops of ferric chloride 
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was added followed by H2SO4 (1ml) along the side of the test tube. The 
formation of the brown ring at the interface gives positive indication for cardiac 
glycoside and a violet ring may appear below the brown ring. 
4. Test for Saponins:
a) Foam test: 0.5gm of extract was shaken with 2ml of water if foam produced 
persists for ten minutes. It indicates the presences of saponins. 
5. Detection of phenols: 
           Ferric Chloride test: Extracts were treated with 3- 4 drops of ferric chloride    
solution. Formation of bluish black colour indicates the presence of the phenols. 
6. Detection of tannins: 
          Gelatin test: The extract was dissolved in 5ml of distilled water and 2ml of 
1% solution of Gelatin containing 10% NaCl was added to it. White precipitate indicates 
the presence of phenolic compounds.
7. Detection of flavonoids:
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium 
hydroxide solution. Formation of intense yellow colour, which becomes 
colourless on addition of dilute acid, indicates the presence of flavonoids. 
8. Detection of Proteins:
a) Xanthoproteic Test: The extracts were treated with few drops of concentrated 
Nitric acid. Formation of yellow colour indicates the presence of proteins. 
9. Detection of Aminoacids: 
a) Ninhydrin Test: To the extract, 0.25% w/v Ninhydrin reagent was added and 
boiled for few minutes. Formation of blue colour indicates the presence of amino 
acid. 
10. Detection of Diterpenes:
a) Copper acetate test: Extracts was dissolved in water and treated with 3-4 drops 
of copper acetate solution. Formation of emerald green colour indicates the 
presence of diterpenes. 
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11. Gum and Mucilage: 
To 1ml of extract, 2.5 ml of absolute alcohol was added and stirred constantly. Then the 
precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
12. Test for Quinones: 
Extract was treated with sodium hydroxide, blue or red precipitate indicates the presence 
of Quinones. 
13. Test for Fixed oils and Fats:
a) Spot Test: A small quantity of extract is pressed between two filter papers. Oil 
stain on the paper indicates the presence of fixed oils. 
HPLC - High Performance Liquid Chromatography (HPLC) 
(75)
: 
          HPLC is a technique in analytical chemistry which is used to separate the 
components in a mixture, to identify each component and to quantify each component. It 
relies on pumps to pass a pressurized liquid solvent containing the sample mixture 
through a column filled with a solid adsorbent material. Each component in the sample 
interacts slightly different with the adsorbent material, causing different flow rates for the 
different components and leading to the separation of the components as they flow out of 
the column. In this study, the detection and quantitation were carried out using 515 HPLC 
pumps and 2489 UV/Visible detectors of Waters Company while the software used was 
Empower. 
       Two methods using different mobile phases were used for chromatographic 
separation of the research drugs – Method I (binary gradient method of Acetonitrile & 
0.1% Phosphoric acid in Water) and Method II (binary gradient method of Methanol 1:25 
Acetic acid in Water). Results obtained during Method I have been discussed since better 
separation of compounds was observed during this analysis. The chromatographic 
conditions for Method I are as given below: 
Column : Symmetry C18, 5 µm, 4.6x250 mm 
Run Time : 30 minutes 
Injection Volume : 20 µl 
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Wavelength (Dual) : 272 nm & 360 nm 
Solvent A : Acetonitrile 
Solvent B : 0.1% Phosphoric acid in water 
Flow rate : 1.0 ml/min. 
Pump Mode : Gradient 
 
4.2.4 BIO-CHEMICAL ANALYSIS 
(76) 
                  The bio-chemical analysis was done to identify the acid and basic radicals 
present in the KKC. 
Preliminary Basic and Acidic radical studies 
Preparation of extract 
                  5gm of KKC was taken in a 250 ml clean beaker and 50 ml of distilled water 
was added to it. Then it was boiled well for about 10 minutes. Then it was allowed to 
cool and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. 
This preparation was used for the qualitative analysis of acidic/ basic radicals and 
biochemical constituents in it. 
 
Test for basic radicals 
1. Test for Potassium 
                  To a pinch of the KKC, 2 ml of sodium nitrate and 2 ml of cobalt nitrate 
solution in 30% glacial acetic acid was added and observed for the presence of yellow 
precipitate. 
2. Test for Calcium 
                 To 2 ml of KKC extract, 2 ml of 4% ammonium oxide solution was added and 
observed for the formation of white precipitate. 
3. Test for Magnesium: 
                To 2ml of KKC extract, drops of sodium hydroxide solution was added and 
watched for the appearance of white precipitate. 
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4. Test for Ammonium: 
               To 2ml of KKC extract few ml of Nessler's reagent and excess of sodium 
hydroxide solution were added and observed for the appearance of brown colour. 
5. Test for Sodium 
Hydrochloric acid was added with a pinch of the KKC, made as paste and 
introduced into the blue flame of Bunsen burner and observed for the appearance of 
intense yellow colour. 
6. Test for Iron (Ferrous) 
               KKC extract was treated with Conc. HNO3 and ammonium thiocyanate and 
waited for the appearance of blood red colour. 
7. Test for Zinc 
           To 2 ml of the KKC extract, drops of sodium hydroxide solution was added and  
Observed for white precipitate formation. 
8. Test for Aluminium 
            To the 2m1 of the KKC extract sodium hydroxide was added in drops and changes 
are noted. 
9. Test for Lead 
            To 2 ml of KKC extract 2ml of potassium iodide solution was added and observed 
for the appearance for yellow coloured precipitate. 
10. Test for Copper 
           A pinch of KKC was made into a paste with con. HCl in a watch glass and 
introduced into the non-luminous part of the flame and observed for blue colour 
appearance. 
            To 2 ml of KKC extract excess of ammonia solution was added and observed for 
the appearance of blue coloured precipitate. 
11. Test for Mercury 
              To 2m1 of the KKC extract sodium hydroxide solution was added and noted for 
yellow precipitate formation. 
12. Test for Arsenic 
               To 2 ml of the KKC extract 2ml of sodium hydroxide solution was added and 
observed for brown or red precipitate. 
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Test for acid radicals 
1. Test for Sulphate 
              To 2 ml of the KKC extract, 5% of barium chloride solution was added and 
observed for the appearance of white precipitate. 
2. Test for Chloride 
             The KKC extract was treated with silver nitrate solution and observed for the 
appearance of white precipitate. 
3. Test for Phosphate 
              The KKC extract was treated with ammonium molybdate and conc. HNO3 and 
observed for the appearance of yellow precipitate. 
4. Test for Carbonate 
           The KKC extract was treated with conc. Hcl and observed for froth appearance of 
effervescence. 
5. Test for Fluoride & Oxalate: 
              To 2ml of KKC extract 2ml of dil. acetic acid and 2ml of calcium chloride 
solution was added and heated and watched for cloudy appearance. 
6. Test for Nitrate: 
             To 1 gm of the KKC copper turnings was added and again conc. H2SO4 was 
added, heated and the test tube was tilted vertically down and observed for any changes. 
 
4.2.5. AVAILABILITY OF MICROBIAL LOAD  
 ANTIMICROBIAL ACTIVITY (
77) 
AGAR- WELL DIFFUSION METHOD 
PRINCIPLE 
The antimicrobials present in the samples are allowed to diffuse out into the medium and 
interact in a plate freshly seeded with the test organisms. The resulting zones of inhibition 
will be uniformly circular as there will be a confluent lawn of growth. The diameter of 
zone of inhibition can be measured in millimeters. 
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MATERIALS REQUIRED 
1.Muller Hinton Agar Medium (1 L) 
The medium was prepared by dissolving 33.8 g of the commercially available Muller 
Hinton Agar Medium (MHI Agar Media) in 1000ml of distilled water. The dissolved 
medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The autoclaved 
medium was mixed well and poured onto 100mm petriplates (25-30ml/plate) while still 
molten. 
2. Nutrient broth (1L) 
One litre of nutrient broth was prepared by dissolving 13 g of commercially available 
nutrient medium (HI Media) in 1000ml distilled water and boiled to dissolve the medium 
completely. The medium was dispensed as desired and sterilized by autoclaving at 15 lbs 
pressure (121ºC) for 15 minutes. 
3. Streptomycin (standard antibacterial agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
1. Escherichia coli (ATCC 25922) 
2. Staphylococcus aureus (ATCC 25923) 
3. Pseudomonas aeroginosa (ATCC 27853) 
4. Klebsiellapneumoniae(ATCC 13883) 
 
PROCEDURE 
Petriplates containing 20ml Muller Hinton Agar Medium were seeded with bacterial 
culture of Escherichia coli, Pseudomonas aeroginosa, Klebsiella pneumonia and 
Staphylococcus aureus (growth of culture adjusted according to McFarland Standard, 
0.5%). Wells of approximately 10mm was bored using a well cutter and different 
concentrations of sample such as 250μg/mL, 500μg/mL and 1000μg/mLwere added. The 
plates were then incubated at 37°C for 24 hours. The antibacterial activity was assayed by 
measuring the diameter of the inhibition zone formed around the well (NCCLS, 1993). 
Streptomycin was used as a positive control. 
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 ANTIFUNGAL ACTIVITY 
(78) 
AGAR- WELL DIFFUSION METHOD  
PRINCIPLE 
In order to access the biological significance and ability of the sample, the antifungal 
activity was determined by Agar well diffusion method. The antifungals present in the 
samples are allowed to diffuse out into the medium and interact in a plate freshly seeded 
with the test organisms. The resulting zones of inhibition will be uniformly circular as 
there will be a confluent lawn of growth. The diameter of zone of inhibition can be 
measured in millimeters. 
MATERIALS REQUIRED 
1) Potato Dextrose Agar Medium (1 L) 
The medium was prepared by dissolving 39 g of the commercially available 
Potato Dextrose Agar Medium (HiMedia) in 1000ml of distilled water. The dissolved 
medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The autoclaved 
medium was mixed well and poured onto 100mm petriplates (25-30ml/plate) while still 
molten. 
2. Clotrimazole (standard antifungal agent, concentration: 10mg / ml) 
3. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
 Aspergillus niger (ATCC 16404)  
 
PROCEDURE 
Potato Dextrose agar plates were prepared and overnight grown species of fungus, 
Aspergillus niger were swabbed. Wells of approximately 10mm was bored using a well 
cutter and samples of different concentrations such as 250μg/mL, 500μg/mL and 
1000μg/mL were added. The zone of inhibition was measured after overnight incubation 
at room temperature and compared with that of standard antimycotic (Clotrimazole) 
(NCCLS, 1993). 
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4.2.6. SOPHISTICATED INSTRUMENTAL ANALYSIS 
  FTIR - Fourier Transform Infra-red Spectroscopy 
(79)
: 
            FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications although it 
can also characterise some inorganics. Examples include paints, adhesives, resins, 
polymers, coatings and drugs. FTIR is an effective analytical instrument for detecting 
functional groups. 
APPLICATIONS: 
 Quantitative scans and Qualitative scan
 Solids, liquids, gases
 Organic samples, inorganic samples
 Unknown identification and Impurities
 Screening formulation
 Pharmaceuticals.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig no.3.1: FTIR INSTRUMENT 
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                                    Fig no.3.2: FTIR MECHANISM 
 
Principle: 
            Spectrophotometric tests are commonly used in the Identification of chemical 
substances and quantification of polymorphic forms. The test procedures are applicable to 
substances that absorb IR radiation. The IR absorption spectrum of a substance compared 
with that obtained concomitantly for the corresponding reference standard / reference 
substance provide conclusive evidence of the identity of the substance being tested. 
 
Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›) : 
 Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg, 
unless otherwise specified, of finely powdered and dried potassium bromide. If 
the substance is a hydrochloride it is preferable to use potassium chloride.
 Carefully grind the mixture and spread it uniformly in a suitable dye.
 Submit it to the pressure of about 800 mPa (8 tons/cm2 ).
 Examine the disc visually and if any lack of uniform transparency is observed, 
reject the disc and prepare again.
 Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in 
individual standard test procedure.
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 When sample and standard are measured for concordance, the transmittance 
obtained at the start of the scan range, should not deviate by more than 10% 
between them ( For eg. If the standard shows a transmittance of 75%, the sample 
transmittance can be between 65% and 85%).
FT-IR was the most advanced and the major advantage was its 
 Speed
 Sensitivity
 Mechanical Simplicity
 Internally Calibrated 

                                  XRD (X-RAY POWDER DIFFRACTION) 
(81) 
Definition 
                 X-ray powder diffraction is most widely used for the identification of unknown 
Crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
Applications 
 Characterization of crystalline materials
 
 Identification of fine-grained minerals such as clays and mixed layer clays that are 
difficult to determine optically
 Determination of unit cell dimensions.
 With specialized techniques, XRD can be used to,
 Determine crystal structures using Rietveld refinement
 Determine of modal amounts of minerals (quantitative analysis)
Characterize thin films samples by:
 Determining lattice mismatch between film and substrate and to inferring stress 
and strain.
 Determining dislocation density and quality of the film by rocking curve 
measurements
 Measuring super lattices in multilayered epitaxial structures
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 Determining the thickness, roughness and density of the film using glancing 
incidence X-ray reflectivity measurements
 Make textural measurements, such as the orientation of grains, in a polycrystalline 
sample.
Strengths and Limitations of X-ray Power Diffraction Strengths
 Powerful and rapid (< 20 min) technique for identification of an unknown mineral
 In most cases, it provides an unambiguous mineral determination
 Minimal sample preparation is required
 XRD units are widely available
 Data interpretation is relatively straight forward








 
 
 
 
 
 
 
                                              Fig no:3.3: Shows Image XRD Analyser 
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                                                 Fig no:3.4: XRD Mechanism 
Limitations 
 Homogeneous and single phase material is best for identification of unknown
 Must have access to a standard reference file of inorganic compounds
 Requires tenths of a gram of material which must be ground into a powder
 For mixed materials, detection limit is ~ 2% of sample
 For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated.
Sample Collection and Preparation
                 Determination of an unknown requires: the material, an instrument for grinding 
and a sample holder. 
 Obtain a few tenths of a gram (or more) of the material, as pure as possible
 Grind the sample to a fine powder, typically in a fluid to minimize inducing extra 
strain (surface energy) that can offset peak positions, and to randomize 
orientation.
 Powder less than ~10 μm (or 200-mesh) in size is preferred place into a  sample  
holder or onto the sample surface
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ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY)  
(82) 
 
 
 
 
 
 
 
 
 
 
 
 
 
                   Fig: 3.5: ICP-OES  INSTRUMENT  ( Perkin Elmer Optima 5300 DV) 
Manufacturer: Perkin Elmer Model 
              Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) in different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights). These releases are separated based on 
their respective wavelengths and their strengths are measured (spectrometry). The 
intensities are proportional to the concentrations of analyses in the aqueous sample. The 
quantification is an external multipoint linear standardization by comparing the emission 
intensity of an unknown sample with that of a standard sample. Multi-element calibration 
standard solutions are prepared from single- and multi element primary standard 
solutions. With respect to other kinds of analysis where chemical speciation is relevant 
(such as the concentration of ferrous iron or Ferric Iron), only total essential 
concentration is analysed by ICP-OES. 
Application 
The analysis of major and minor elements in solution KKC. 
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Objectives 
 Determine elemental concentrations of different metals.
 Learn principles and operation of the ICP-OES instrument
 Develop and put on a method for the ICP-OES sample analysis
 Enhance the instrumental conditions for the analysis of different elements 
Probes the outer electronic structure of atoms.
Mechanism 
             In plasma emission spectroscopy (OES), a sample solution is presented into the 
core of Inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light is collected by the spectrometer 
and passes through a diffraction grating that serves to resolve the light into a spectrum of 
its essential wavelengths. Within the spectrometer, this deflected light is then collected by 
wavelength and amplified to yield an strength of measurement that can be converted to an 
elemental concentration by comparison with standardization values. The Inductively 
coupled plasma optical emission spectrometric (ICP-OES) analysis was done in SAIF, 
IIT MADRAS, Chennai-36 using Perkin Elmer Optima 5300 DV. Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" sampling 
methods whereby samples are introduced in liquid form for analysis. 100 mg RSP was 
occupied in a clean, dry test tube. To this, 3 ml Nitric acid was added and mixed well and 
allowed for few minutes until the reactions were completed. And then, 25 ml of Refined 
water, was added to prepare digested solution. 
                The digested sample solution was shifted into plastic containers and labelled 
properly. It was completed in Bio-chemistry lab, Govt. Siddha Medical College, 
Chennai-106. 
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 Fig.5.2.  ICP-OES MECHANISM 
 
SEM (Scanning Electron Microscope) 
(83) 
DEFINITION
 
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high magnifications, 
generates high-resolution images and precisely measures very small features and objects.
 
SEM ANALYSIS APPLICATIONS 
The signals generated during SEM analysis produce a two-dimensional image and 
reveal information about the sample including: 
External morphology (texture), Chemical composition (when used with EDS) 
Orientation of materials making up the sample. 
The EDS component of the system is applied in conjunction with SEM analysis to: 
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 Determine elements in or on the surface of the sample for qualitative information 
 Measure elemental composition for semi-quantitative results 
 Identify foreign substances that are not organic in nature and coatings on metal 
 SEM Analysis with EDS – qualitative and semi-quantitative results 
 Magnification – from 5x to 300,000x 
 Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in height 
 Materials analysed – solid inorganic materials including metals and minerals. 
 
 
 
 
 
 
 
 
        
 
                                        Fig no:3.7. SEM INSTRUMENT 
 
 
 
 
 
 
 
 
 
 
 
 
                                          Fig.no.3.8 SEM MECHANISM 
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THE SEM ANALYSIS PROCESS 
Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens. In most SEM microscopy 
applications, data is collected over a selected area of the surface of the sample and a two-
dimensional image is generated that displays spatial variations in properties including 
chemical characterization, texture and orientation of materials. The SEM is also capable 
of performing analyses of selected point locations on the sample. This approach is 
especially useful in qualitatively or semi-quantitatively determining chemical 
compositions, crystalline structure and crystal orientations. 
The EDS detector separates the characteristic X-rays of different elements into an 
energy spectrum and EDS system software is used to analyse the energy spectrum in 
order to determine the abundance of specific elements. A typical EDS spectrum is 
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to the 
various elements in the sample. Energy Dispersive X-ray Spectroscopy can be used to 
find the chemical composition of materials down to a spot size of a few microns and to 
create element composition maps over a much broader raster area. Together, these 
capabilities provide fundamental compositional information for a wide variety of 
materials, including polymers. In scanning electron microscope high-energy electron 
beam was focused through a probe towards PP. Variety of signals was produced on 
interaction with the surface of the sample. This results in the emission of electrons or 
photons and it was collected by an appropriate detector. 
The types of signal produced by a scanning electron microscope include:  
 Secondary electrons 
 Back scattered electrons 
 Characteristic x-rays light 
 Specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample. 
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4.3. TOXICOLOGICAL STUDIES 
4.3.1. ACUTE ORAL TOXICITY – OECD GUIDELINES – 423 
INTRODUCTION: 
              The acute toxic class method was a stepwise procedure with the use of 3 animals 
of a single sex per step. Depending on the mortality and/or the moribund status of the 
animals, on average 2-4 steps may be necessary to allow judgment on the acute toxicity 
of the test substance. Morbid animals or animals obviously in pain or showing signs of 
severe and enduring distress shall be humanely killed, and are considered in the 
interpretation of the test results in the same way as animals that died on test. The method 
allows for the determination of an LD50 value only when at least two doses result in 
mortality higher than 0% and lower than 100%. 
         Acute toxicity study was carried out as per OECD (Organization for Economic Co - 
operation and Development) guideline-423. 
           The experimental protocol was approved by the Institutional Animal Ethical 
Committee (IAEC) under CPCSEA (Approval no: 02/321/PO/Re/S/01/CPCSEA dated 
12/10/2018) at C.L.Baid Metha college of Pharmacy, Thuraipakkam, Chennai. 
 
PRINCIPLE: 
            It was the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information was obtained on the acute 
toxicity of the test substance to enable its classification. The substance was administered 
orally to a group of experimental animals at one of the defined doses. The substance was 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e.; − no further testing was needed − dosing of three additional 
animals with the same dose − dosing of three additional animals at the next higher or the 
next lower dose level. The method will enable a judgment with respect to classifying the 
test substance to one of a series of toxicity classes
 (84)
. 
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METHODOLOGY 
Selection of animal species: 
 The animal models used in this study were albino animals. 
 Healthy Female albino animals weighing 150-250gm were obtained from the 
Animal house of King’s institute, Guindy, Chennai. 
 Females should be nulliparous and non-pregnant. 
 Each animal must be around 8 and 12 weeks old at the time of dosing. 
 The studies were conducted in the animal house of C.L.Baid Metha college of 
Pharmacy, Thuraipakkam, Chennai-97. 
Housing and feeding conditions: 
 Animals were housed under standard laboratory conditions. 
 They were maintained in a ventilated room. The temperature in the room should be 
22º(+3º).  
 The relative humidity should be at least 30% and not exceed 70% (50%-60%). 
 Lighting should be artificial; it is maintained as 12 hours light, 12 hours dark 
cycle.  
 Animals were kept in a clean polypropylene cage. 
 Animals were fed with standard pellet diet (Biogen Foods, Bangalore) and water 
and libitum. 
Preparation of animals: 
         All the animals were randomly selected and marked on its fur for its individual 
identification. They were acclimatized to the laboratory conditions at least one week 
prior to the commencement of the study. 
Preparation for Acute Toxicity Studies 
             Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the Kandankathari Chooranam. 
            The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
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Test Substance : KANDANKATHARI CHOORANAM 
Animal Source : TANUVAS, Madhavaram, Chennai. 
Animals : Wister Albino Rats (Female-3+3) 
Age : 8-12 weeks 
Body Weight on Day 0 : 200-220gm. 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual 
      marking by using Picric acid. 
Number of animals : 3 Female/group, 
Route of administration : Oral 
Diet :  Pellet  feed  supplied  by  Sai  meera  foods  Pvt  Ltd, 
                                        .       Bangalore   
Water : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages 
      provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC. 
Relative humidity : between 30% and 70%, 
Air changes : 10 to 15 per hour and 
Dark and light cycle : 12:12 hours. 
Duration of the study : 14 Days 
EXPERIMENT PROCEDURE: 
Administration of doses 
             KANDANKATHARI CHOORANAM prepared as per the classical Siddha literature 
was suspended in 2% CMC with uniform mixing and was administered to the groups of 
Wistar albino rats. It was given in a single oral dose by gavage using a feeding needle. 
Animals were fasted prior to dosing. Following the period of fasting, the animals were 
weighed and then the test substance was administered. After the substance has been 
administered, food was withheld for a further 3-4 hours. The principle of laboratory 
animal care was followed. Observations were made and recorded systematically and 
continuously observed as per the guideline after substance administration. 
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             The visual observations included skin changes, mobility, aggressiness, sensitivity 
to sound and pain, as well as respiratory movements. They were deprived of food, but not 
water 16–18 hours prior to the administration of the test suspension. Finally, the number 
of survivors was noted after 24 hours and these animals were then maintained for a 
further 14 days and observations made daily. The toxicological effect was assessed on 
the basis of mortality. 
Number of animals and dose levels 
          Since this test drug has been under practice for long time and likely to be non-toxic, 
a limit test at one dose level of 2000 mg/kg body weight will be carried out with 6 
animals (3 animals per step). 
                 Duration of Study       :         48 hours 
                 Evalution                   :          14 Days 
Limit test 
         The limit test was primarily used in situations where the experimenter has 
information indicating that the test material was likely to be nontoxic, i.e., having toxicity 
only above regulatory limit doses. A limit test at one dose level of 2000 mg/kg body 
weight was carried out with three animals per step. The test substance-related mortality 
was not produced in animals, so further testing at the next lower level need not be carried 
out. 
Observations 
The animals were observed individually after dosing at least once during the first 
30 minutes and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug and it is observed 
daily thereafter for a total of 14 days, except when they needed to be removed from the 
study and killed humanely for animal welfare reasons or are found dead. 
Mortality: 
      Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 hours 
following drug administration on day 1 of  the experiment and daily twice thereafter for  
14 days. 
Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study. 
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Cage-side observation 
            These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
 
Gross necropsy 
          All animals (including those which die during the test period are removed from the 
study) will be subjected to gross necropsy. Gross necropsy includes examination of the 
external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and 
uterus of all animals. 
 
Histopathology 
        Microscopic examination will be carried out in organs to show the evidence of any 
toxicity in gross pathology. 
Data and reporting 
        All the data were summarised in tabular form showing the animals used, number of 
animals displaying signs of toxicity, the number animals found dead during the test or 
killed for humane reasons, a description and the time course of toxic effects and 
reversibility and necropsy findings. 
 
Test substance and Vehicle 
         In order to ensure the uniformity in drug distribution in the medium the suspension 
was made by mixing KANDANKATHARI CHOORANAM with 2% CMC solution and it 
was found suitable for dose accuracy. 
 
Justification for choice of vehicle 
          The vehicle selected as per the standard guideline was pharmacologically inert and 
easy to employ for new drug development and evaluation technique. 
(85)
. 
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4.3.2.REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF 
KANDANKATHARI CHOORANAM (KKC) ON RATS – (OECD- 407 guidelines) 
Test Substance : Kandankathari Chooranam  
Animal Source : TANUVAS, Madhavaram, Chennai.  
Animals : Wister Albino Rats (Male -24, and Female-24s) 
Age : 6-8 weeks  
Body Weight : 150-220gm.  
Acclimatization : Seven days prior to dose.  
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number  and Individual 
 marking by using  Picric acid  
Diet :  Pellet  feed  supplied  by  Sai  meera foods  Pvt  Ltd, 
                                           Bangalore    
Water : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages 
       provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC.  
Relative humidity : between 30% and 70%,  
Air changes : 10 to 15 per hour  
Dark and light cycle : 12:12 hours.  
Duration of the study : 28 Days.  
 
Justification for Dose Selection 
        The results of acute toxicity studies in Wistar albino rats indicated that 
KANDANKATHARI CHOORANAM  was non-toxic and no behavioral changes was 
observed up to the dose level of 2000 mg/kg body weight. On the basis of body surface 
area ratio between rat and human, the doses selected for the study were 100mg/kg, 200 
mg/kg and 400 mg/kg body weight. The oral route was selected for use because the oral 
route was considered to be a proposed therapeutic route 
(86)
. 
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Preparation and administration of dose 
         KANADANKATHARI CHOORANAM  at three doses respectively was suspended in 
2 ml of 2% CMC in distilled water. It was administered to animals at the dose levels of 
100, 200 and 400 mg/kg. The test substance suspensions were freshly prepared every day 
for 28 days. The control animals were administered vehicle only. Administration was by 
oral (gavage), once daily for 28 consecutive days. 
 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals 
Twelve rats (Six Male and Six Female) were in each group randomly divided into 
four groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 
days to laboratory conditions prior to the initiation of treatment. Each animal was fur 
marked with picric acid. The females were nulliparous and non-pregnant. 
   Table 1 
                      Groups                   No of  Rats 
Group I Vehicle control (Normal Saline )  12 (6 male, 6 female) 
Group II KKC  100 mg / kg 12 (6 male, 6 female) 
Group III KKC 200 mg / kg 12 (6 male, 6 female) 
Group IV KKC 400 mg / kg 12 (6 male, 6 female) 
KKC-Kandankathari Chooranam. 
 
 
OBSERVATIONS 
Experimental animals were kept under observation throughout the course of study 
for the following: 
Body Weight:  
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percent body weight gain were calculated. 
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Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality:  
All animals were observed twice daily for mortality during entire course of study. 
Functional Observations:  
At the end of the 4
th
 week exposure, ‘sensory reactivity’ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and ‘grip 
strength’ were assessed. 
Laboratory Investigations:  
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for Haematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
  On 28th day of the experiment, 24 hours urine samples were collected by placing 
the animals in the metabolic cage with free access to tap water but no feed was given.The 
urine was free from fecal contamination. Toluene was used as a preservative while 
collecting the sample. The sediments present in the urine were removed by centrifugation 
and the collected urine was used for biochemical estimations. 
On 29th day, the animals were fasted for approximately 18 hours, then slightly 
anesthetized with ether and blood samples were collected from the retro-orbital plexus 
into two tubes : one with EDTA for immediate analysis of haematological parameters, the 
other without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes 
to obtain the serum. Serum was stored at 20 °C until analyzed for biochemical 
parameters. 
Haematological Investigations:  
Blood samples of control and experimental rats were analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV). 
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Biochemical Investigations:  
Serum was used for the estimation of biochemical parameters. Samples of control 
and experimental rats were analyzed for protein, bilirubin, urea, BUN, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. 
Activities of glutamate oxaloacetate transaminase/ Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine  amino transferase (GPT/ALT) 
and alkaline phosphatase were estimated as per the colorimetric procedure. 
Urine analysis:  
Urine samples were collected on end of the treatment for estimation of normal 
parameters. The estimations were performed using appropriate methodology. 
Necropsy:  
All the animals were sacrificed on day 29. Necropsy of all animals were carried 
out and the weights of the organs including liver, kidneys, spleen, brain, heart, and lungs 
were recorded. The relative organ weight of each animal was then calculated as follows; 
Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
                                                              Body weight of animal on sacrifice day (g) 
Histopathology:  
Histopathological investigation of the vital organs was done. The organ pieces (3-
5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed in 10% 
formalin for 24 hours and washed in running water for 24 hours. Samples were 
dehydrated in an auto technicon and then cleared in benzene to remove absolute alcohol. 
Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” moulds. 
It was followed by microtome and the slides were stained with Haematoxylin-eosin. The 
organs included heart, kidneys, liver, ovary, pancreas, brain, spleen and stomach of the 
animals were preserved they were subjected to histopathological examination. 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-way ANOVA 
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followed by Dunnet’s multicomparision test using a computer software programme 
GRAPH PAD-8 version. 
4.4. PHARMACOLOGICAL ACTIVITIES: 
4.4.1. Evaluation of Bronchodilator activity: 
Overnight fasted guinea pigs were divided into four groups each containing 6 animals. 
 Group 1 was treated as control, 
 Group 2 received standard drug chlorpheniramine maleate (2 mg/kg).
 Group 3 Kandankathari Chooranam 200 mg/kg.
 Group 4 Kandankathari Chooranam 400mg/kg.
             All the doses were given orally once a day for 5 days. Prior to drug treatment 
each animal was placed in the histamine chamber and exposed to 0.2 % histamine 
aerosol. The pre convulsive time (PCT) was determined from the time of exposure to 
onset of convulsions. As soon as the PCT were noted, the animals were removed from the 
chamber and placed in fresh air. Group 2 received Chlorpheniramine maleate. These 
animals were again subjected to histamine aerosol after 1hour of drug administration and 
PCT was determined. The protection offered by treatment was calculated by using the 
formula 
(87)
. 
    Percentage Protection = (1 - T1/T2) X 100 Where, 
                          T1 = the mean of PCT before administration of test drugs. 
                          T2 = the mean of PCT after administration of test drugs. 
4.4.2. Evaluation of Antihistamine activity: 
Vascular permeability test in rats:   
Immediately after an i.v. injection of 1 ml of 1 Evans blue in physiological saline, 
two sites on one side of the shaved back of animals were injected intradermally with 0.1 
ml of physiological saline containing 0.1 µg histamine, contralateral sites were injected 
intradermally with an equal volume of physiological saline (the control skin areas). 
Kandankathari Chooranam was given orally 30 min in rats prior to the injection of 
phlogistics. Thirty minutes later, the animals are sacrificed by overdose of anesthesia, and 
the skin was removed. Exudation of dye was calculated by subtracting the amount 
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determined in the control skin area and expressed as the mean of two values obtained in 
each animal 
(88)
. 
 
Calculation: 
Area of protection = control area – area of exudation of dye 
Grouping: Wistar rats were used for the study n=6nos 
Group 1----------Control group 
Group 2----------Standard drug Cetrizine 20mg 
Group 3----------Kandankathari Chooranam 200mg/kg 
Group 4----------Kandankathari Chooranam 400mg/kg 
Experimental Procedure 
         Guinea pig was sacrificed and a segment from ileum (2 cm) was dissected from the 
terminal ileum and mounted in an organ bath containing Tyrode solution (10 ml) between 
two stainless steel hooks under 0.5 to 1 g initial tension. The lower hook was fixed at the 
bottom of the organ bath and upper one was connected to an isotonic transducer. The 
Tyrode solution composition (pH 7.4) was NaCl-8.0, KCl-0.2, CaCl2-0.2, MgCl2-0.1, 
NaHCO3 -1.0, NaH2PO4-0.05, and Glucose-10.0gms/liter. 
        It was continuously aerated and maintained at 37 ± 0.5ºC. The equilibrium period 
was 60 min and the bath solution was refreshed every 15 min. After equilibrium period, a 
dose response curve for histamine in variant molar concentrations, by maintaining 45 min 
time cycle was taken separately. Results are provided in the table 
Statistical Analysis 
       Ileum contractions induced by agonist were assumed as 100% and reductions 
induced by test drug calculated. Percentage of ileum contraction was expressed as mean 
± SEM. Results were analyzed using one-way analysis of variance (ANOVA). 
Probability value less than 0.05 were considered as significant. Results are discussed in 
table. 
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Method: 
       After the end of sub-acute toxicity study, the intermediate dosage groups of animals 
were sacrificed and organs such as liver and kidneys were excised out and analyzed for 
oxidative stress markers. The concentration of oxidative stress markers such as Lipid 
peroxide, Glutathione, Glutathione peroxidase and Catalase were analyzed. Lipid 
peroxides (Thiobarbituric Acid Reactive Substances – TBARS) in tissues were assayed 
by the method of Yagi (Yaki K, 1978). The colour formation with Thiobarbituric acid 
(TBA) was used as index. Reduced glutathione (GSH) was estimated by the method of 
Ellman in which yellow colour developed when dithionitro-bis-benzoic acid (DTNB) 
added to the compounds sulfhydryl groups (Ellman GL, 1959). Glutothione peroxidase 
(GPx) estimated by the method of Rotruck et al, 1973 in which H2O2 reduced to water 
whereas organic hydroperoxides reduced to alcohol at the expense of GSH (Rotruck JT et 
al. 1973). The activity of Catalase (CAT) was determined by the method of Sinha (Sinha 
AK, 1972). In this assay, Dichromate in acetic acid heated in the presence of hydrogen 
peroxide converted to perchromic acid and then to chromic acetate. The formed chromic 
acetate was measured at 620 nm. 
 
4.4.3. Evaluation of Antioxidant activity (In-Vitro Model): 
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) 
            The radical scavenging activity of KKC extracts was determined by using DPPH 
assay according to Chang et al. (2001). The decrease in the absorption of the DPPH 
solution after the addition of an antioxidant was measured at 517nm. Ascorbic acid 
(10mg/ml DMSO) was used as reference. 
Principle 
            1, 1 Diphenyl 2- Picryl Hydrazyl is a stable (in powder form) free radical with red 
color which turns yellow when scavenged. The DPPH assay uses this character to show 
free radical scavenging activity. The scavenging reaction between (DPPH) and an 
antioxidant (H- A) can be written as, 
                                   (DPPH) + (H-A) → DPPH-H + (A) 
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  Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
 Reagent preparation 
          0.1mm DPPH solution was prepared by dissolving 4mg of DPPH in 100ml 
of ethanol. 
Procedure 
Different volumes (1.25-20µg/µl) of KKC extracts were made up to 40µl with 
DMSO and 2.96ml DPPH (0.1mm) solution was added. The reaction mixture was 
incubated in dark condition at room temperature for 20 minutes. After 20 minutes, the 
absorbance of the mixture was read at 517 nm. 3ml of DPPH was taken as control.  
        The % radical scavenging activity of the KKC extracts was calculated using the  
following formula, 
 
                                                                                 Control – test 
 Percentage of inhibition  = 
 
× 100 
 
                                                                                    Control 
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5. RESULTS AND DISCUSSION 
         Many studies have been carried out to bring the efficacy and potency of the drug 
Kandankathari Chooranam. The studies includes Literary collections, Organoleptic 
character, Physicochemical and Phytochemical analysis, Microbial load, Instrumental 
analysis, Toxicological studies and Pharmacological studies. The drug Kandankathari 
Chooranam has been selected for Bronchodilator activity in reference with the text 
“Agathiyar Attavanai Vagadam”. 
Discussion on review of literature: 
 Literary collections about the drug from various text books were done. Siddha 
literatures related to ingredients of the drug bring the evidence and importance of its 
utility in treating Bronchial Asthma.

 Botanical aspect explains the identification, description, active principle and 
medicinal uses of the Ingridents.

  Gunapadam  review  brings  the  effectiveness  of  the  drug  in  treating Bronchial 
Asthma.

 Pharmaceutical review describes about the Chooranam and its properties.

 The Pharmacological review  explains about the  methodology  of  Bronchodilator 
Activity and Anti histamine activity.

 Modern and Siddha aspect of the disease was also reviewed.

Standardization of the test drug: 
            Standardisation of the drug is more essential to derive the efficacy and the potency 
of the drug by analysing it by various studies. Following are the results of 
physicochemical and phytochemical analysis. Physical characterisation and estimation of 
basic and acidic radicals have been done and tabulated. 
RESULTS AND DISCUSSION 
 
BRONCHODILATOR ACTIVITY OF KANDANKATHARI CHOORANAM Page 94 
 
          Toxicological results of the drug and pharmacological activity of the drug was 
derived. Its result has been tabulated and the interpretation was made below. Thus it give 
a complete justification to bring the effectiveness of the trial drug Kandankathari 
Chooranam. 
        The extensive review on botanical aspect gave information about the microscopical 
characters, macroscopical characters, medicinal uses, constituents and the  importance of 
the herbs in detail. Most of the herbs included in this  preparation  exhibit bronchodilator 
effect which is useful in the treatment of bronchial asthma. 
             Solanum xanthocarpum exhibits expectorant and anti-inflammatory actions. It 
produces diminishing effect in the intensity of cough and dyspnoea 
(89)
. 
              Zingiber officinale relaxes the airway smooth muscle and potentially serve as 
novel bronchodilator 
(90)
. It also possesses anti-oxidant activity 
(91)
. 
           Piper nigrum has contains a pungent alkaloid ‘‘Piperine’’ which is known to 
possess many pharmacological actions like antioxidant, anti-asthmatics, anti-
inflammatory, anti-diarrheal, antispasmodic, immunomodulatory activity. All these 
activities primarily favours the treatment of bronchial asthma 
(92)
. 
           Piper longum also have Piperine,  which  is  the  prime  constituent  of  fruit which 
have   significant  anti - inflammatory  and  antioxidant  activity 
(93)
. It  also  possesses 
expectorant effect and is commonly used for Bronchial asthma 
(94)
. 
            Toddalia asiatica is used for treatment of cough, fever and  epilepsy  and  also  as 
and expectorant, analgesic, diaphoretic and anti-inflammatory 
(95)
. 
Discussion on pharmacological aspect: 
 The pharmacological aspect of the drug says about their mode of action and the 
side effects which were used worldwide since ancient times.
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 The current pharmacological methods available for carrying out the 
Bronchodilator studies were explained clearly and the suitable In-vivo models 
carry out the activities were discussed.
 Result from the pharmacological study denotes the effects of Kandankathari 
Chooranam (KKC) showed the promising effects in treating lung diseases.
Discussion on Pharmaceutical review: 
 This review explained the preparation of Chooranam in detail including the 
purification of raw drugs, methods of manufacturing of Chooranam and the 
Siddha parameters for the standardization of  Chooranam.
 The powdered drugs were filtered through the white cloth so as to reduce the size 
of the particle in turn which enhances the bio-availability.
 The  shelf  life  of  the  drug  is  improved  by   proper  purification   methods  and 
preservation.
Discussion on Materials and Methods: 
 The preparation of the drug was done carefully so as to achieve the highest 
potency. Chooranam are fine, dry powders of drugs. The term Chooranam may 
be applied to the powder of single drug or a mixture of two or more drugs.
 On  purification  (pittaviyal),  the  weight  of  the Chooranam is different from the 
exact value but not from the mean value when calculated.
 The Chooranam are also subjected to Siddha parameters of the testing like,
                                Chooranam tends to be amorphous,
                                 It should be never damp,
                                 The fitness of the sieve should be 100 mesh or still finer.
 The standardization of the drugs was achieved through various procedures like 
analyzing the organoleptic characters, physico-chemical characters, elements 
present in the drug and the results and discussion of standardization parameters 
are described below.

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ORGANOLEPTIC CHARACTER: 
Table: 2 Results of  Organoleptic characters 
S.No Parameter Results 
1. Colour Brown 
2. Odour Characteristic odour 
3. Taste Pungent & Sweet 
4. Sense of touch Fine powder 
5. Size 
Completely pass through 
sieve no 88  
 
PHYSICOCHEMICAL ANALYSIS: 
Table: 3. Results of Physicochemical Analysis: 
S.NO PARAMETERS PERCENTAGE 
1. PH 6.08 
2. Loss on drying  0.99% 
3. Total ash value 5% 
4. Acid insoluble ash 1% 
5. Water soluble ash 1% 
6. Water soluble extraction 30.4% 
7. Alcohol soluble extraction 10% 
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8. 
Solubility  
1.Distilled water Soluble 
2.Ethonal Soluble 
3.Chloroform Soluble 
 
The  physicochemical  analysis  of  the drug  (KKC)  result  reveals  pH,  Loss on 
drying total ash value, Acid insoluble ash and Water soluble ash. The interpretation of the 
result were given below. 
Interpretation: 
1. pH: 
         It is a measure of hydrogen ion concentration. It is the measure of the acidic or 
alkaline nature. 7.0 is neutral, above 7.0 is alkaline and below is acidic. 
     The pH of the drug Kandankathari Chooranam is 6.08 which is weak acidic in nature. 
Acidic drug is essential for its bioavailability and effectiveness. Acidic drugs are better 
absorbed in stomach.
(96)
. 
2. Moisture (Loss on drying): 
       The total amount of volatile content and moisture present in the drug was established 
in loss on drying. High moisture content can adversely affect the active ingredient of the 
drug. Thus low moisture content could get maximum stability and better shelf life. Loss 
on drying of Kandankathari Chooranam is 0.99% 
(97)
. 
3. Total Ash: 
        Ash constitutes are the inorganic residues obtained after the complete combustion of 
a drug. Thus Ash value is a valid parameter to describe and to assess the degree of purity 
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of a given drug. Total ash value of plant material indicated the amount of minerals and 
earthy materials present in the drug. The total ash value of Kandankathari Chooranam is 
5%  which determine the absence of inorganic content. 
4. Acid insoluble ash: 
            The acid insoluble ash value of the drug denotes the amount of siliceous matter 
present in the plant. The quality of the drug is better if the acid insoluble value is low. 
Acid insoluable ash value of  Kandankathari Chooranam is 1%. Thus the medicine is 
highly effective. 
5. Water soluble ash: 
       Water-soluble ash is the part of the total ash content, which is soluble in water. 
Decreased water soluble ash value indicates easy facilitation of diffusion and osmosis 
mechanism. Water soluble ash value of Kandankathari Chooranam is 1%. Thus the 
medicine is highly effective. 
6. Solubility: 
        Solubility is the major factor that controls the bioavailability of a drug substance. It 
is useful to determine the form of drug and processing of its dosage form. 
        The most frequent causes of low oral bioavailability are attributed to poor solubility 
and low permeability .
(98)
. 
       KKC is soluble in major solvents and sparingly soluble in some solvents proves that 
its efficiency of solubility in the stomach indirectly, increasing the bio availability. 
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PHYTOCHEMICALS ANALYSIS 
         Table: 4. Results of Phytochemicals screening test: 
S.NO PHYTOCHEMICALS         TEST NAME H2O EXTRACT 
1.  Carbohydrates Molisch’s test  +Ve 
2.  Glycosides Modified Borntrager’s test  +Ve 
3.  Saponins Foam test +Ve 
4.  Flavonoids Alkaline reagent test +Ve 
5.  Diterpenes Copper acetate test +Ve   
6.  Gum and Mucilage Extract + Alcohol +Ve       
                     The above stated phytochemical properties for the given sample certified to 
be present. 
 
 
 
 
 
 
Fig.no.4. Preliminary phytochemical analysis of Kandankathari chooranam 
The phytochemical analysis of the drug (KKC) result reveals Carbohydrats, 
Glycosides, Saponins, Flavanoids, Diterpenes and Gum and Mucilage. The 
interpretations of the result were given below. 
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Interpretation: 
Carbohydrate:
 Carbohydrate contains plenty of antioxidants, vitamins and fiber that are ecessary 
for our health.Carbohydrates provide energy for physical activity and functions of 
the body. Repair of epithelial tissue injury in asthma was made by carbohydrates. 
 Carbohydrates plays an important role in storage of glucose. It regulates the blood 
glucose level and provides energy to the body.
 Carbohydrates help in fat metabolism. It plays an important role in homeostasis.
 Carbohydrates help  us to  fight inflammation  and  cancer, improve our digestive 
system, heart and bone health.
 (99)
.
Glycosides: 
 Glycosides inhibit eosinophil accumulation in tissue and allergic inflammation.
 Many  plants  store  chemicals  in  the  form  of  inactive glycosides, such plant 
glycosides are used as medications. Glycosides  have  antibacterial  activity, so 
they protect our body from bacteria and infectious diseases.
 Glycosides increase the intestinal motility. So it produces laxation.
 
They can be 
Effectively used  for preventing or treating allergic diseases associated with 
inflammation and eosinophil accumulation such as COPD, Bronchial asthma and 
Allergic rhinitis 
(100)
.
Saponins:
 It has anti-spasmodic, anti-inflammatory, expectorant and anti-oxidant property.
 Saponins quicker the expulsion of mucous from the lung.
 In the digestive tract, saponins produce an emulsification of fat soluble molecules. 
Saponins bind with bile acids and helps to eliminate them from the body, 
preventing cholesterol from being reabsorbed.
 Saponins can boost the immune system, have an antioxidant effect and may even 
support bone strength.
(101)
.
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Flavanoids:
 It is the most important group of polyphenolic compounds in plants.
 Flavonoids can exert their anti-oxidant activity by scavenging the free radicals, by 
chelating metal ions or by inhibiting enzymatic systems responsible for free 
radical generation.
 Flavanoids are immunomodulator. It also possesses anti-microbial activity which 
is confirmed by the various anti-microbial assays.
(102).
.
Diterpenes:
 Diterpene has an Anti-oxidant, Anti-inflammatory and mucolytic activity. 
 Diterpenes helps to cure hypertension. It also has tumour inhibitory properties as 
well as a stimulating effect on the immune system.
 Suppress the inflammatory response.
 They are often expectorant.
(103)

Gum and Mucilage:
 Gum is used as a bulk laxatives and mucilage are used for their demulcent 
properties for cough suppression.
(104).
          A synergistic effect of all these Carbohydrate,  Glycosides,  Saponin, Triterpenes 
and Flavonoids increases the potency of the drug against Bronchial asthma. 
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High Performance Liquid Chromatography (HPLC): 
  HPLC analysis were done. HPLC  analysis  performed  with  Kandankathari 
Chooranam revealed the pressence of following compounds: 
Table:5 
S.No PARAMETERS METHOD UNITS RESULTS 
1. Total polyphenol as 
gallic acid equilant 
Indian pharmacopoeia 
2014 
Mg.100g 0.09 
2. Total flavonoids as 
quercetin equivalent 
TNTH/STP/FOOD/110 Mg/100g 18.15 
3. Total alkaloids TNTH/STP/FOOD/426 Mg/100g 1.93 
4. Total tannin as acid 
equivalent 
AOAC20th Edn.2012, 
955.35 
Mg/100g 0.98 
 
         HPLC analysis reveals the pressence of polyphenols, Flavanoids, 
Alkaloids  and Tannins. 







 
                                                                      Chart no.1 
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Interpretation: 
 Polyphenols are the member of very large family of plant derived compounds 
which had the anti lipidogenic effect. This is mainly due to reduce fatty acid and 
triglycerol synthesis, increased in fatty acid oxidation and reduction of oxidative 
stress and inflammation.
 Polyphenols are biomolecules which produce Bronchodilator effects which reduce 
the fat accumulation, mainly by reducing lipogenesis and by increasing fatty acid 
oxidation and decrease oxidative stress and inflammation.
(105)
.
 Flavanoids a group of plant compounds which have the beneficial effects of  
Bronchial asthma.
 Flavanoids prevent Hepatosteatosis by increasing fatty acid oxidation in liver. 
They can also reduce caloric intake and decrease the body weight and fat 
deposition in viseral tissues.
 Flavanoids  are  the  unique  antioxidant. It  also  correct  dislipidemia  and  blood 
pressure
(106)
.
 Tannins  and  alkaloids  contains  anti-oxidant  effect  which  produce  many 
essential effects in protecting the body.
s
BIO CHEMICAL ANALYSIS: 
                        Table: 6.Results of basic radicals studies:
S.no  Parameter Observation Result 
  1  Test for Potassium Yellow colour precipitate Positive 
  2 Test For Magnesium White colour precipitate Positive 
  3 Test for Iron (Ferrous) Blood red colour Positive 
  4 Test For Calcium White Precipitate Positive 
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The basic radical test reveals the presence of Potassium, Magnesium, Iron and 
Calcium. The interpretation of the result were given below. 
Interpretation: 
Presence of these traces of minerals play an important role in the functioning 
of various enzymes in biological system and also have immunomodulatory function 
and hence the susceptibility to the course and the variety of viral infections. 
Potassium: 
 Potassium levels may be an indicator of impending lung problems.
 Potassium is absorbed through the small intestine. Severe lack of potassium 
can disturb the lung function and if potassium level falls below 30% to 40% 
causes Respiratory Disorders.
 Potassium  is  important  for  maintaining  the  integrity of cell membranes and 
functions as a vital electrolyte.
(107).
Magnesium: 
 Magnesium ions are responsible for bronchodilator and anticholinergic action 
which helps in acute asthma. 
 It also helps to regulate blood glucose levels and aid in the production of energy 
and protein
(108).
.
Iron: 
 Presence  of  iron  in  the  drug  has  increased  haemoglobin concentration in the 
blood. 
 It enhances the arterial oxygen level. 
 The drug enhances oxygen supply, promotes the normal ventilation of the lungs 
and reduces the dyspnea. 
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 It also reduces airway hyperactivity and eosinophilia.
(109)
. 
Calcium: 
 Calcium is important for normal muscle contraction and blood vessel structure. 
 Calcium is a cell signaling mineral, which means it plays a vital role in cell-to-
cell communication. Contraction and expansion of respiratory muscles allows 
the lungs to breathe in and out. 
 Calcium is crucial for muscle movement and it helps an individuals to maintain 
normal breathing rhythm. 
            So  Calcium,  Potassium,  Magnesium and  Iron  of  this  drug  help to achieve its 
activity on bronchial muscles.
(110)
. 
Table: 7. Results of acid radical studies: 
S.NO    Parameter    Observation    Result 
1 Test for Chloride Formation of white 
precipitate 
Positive 
2 Test for Phosphate Formation of yellow 
precipitate. 
Positive 
 
Interpretation: 
The  acid  radical  study  of  KKC  shows  the  presence  of  Chloride and 
Phospate. 
Chloride 
 Chloride is needed to keep the proper balancing of body fluids 
(111))
.
 It maintains proper blood volume and pressure 
(112)
.
 It plays critical roles in inflammatory airway diseases such as Bronchial asthma
and Allergic rhinitis 
(113)
. 
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Phosphate 
 Phosphate is a charged particle that contains the mineral phosphorus 
(114)
.
 The mineral Phosphorus is primarily used for growth and repair of body cells and 
tissues
(115)
.
 It reduces the histamine release by activated mast cells 
(116)
.
 
AVAILABILITY OF MICROBIAL LOAD IN KANDANKATHARI CHOORANAM
                                                           GRAM POSITIVE 
Table 8:  Organism: Staphylococcus aureus 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Kandankathiri Choornam 
(KKC) 
Streptomycin (100µg) 26 
250 16 
500 17 
1000 18 
14mm- Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
GRAM NEGATIVE 
Table: 9: Organism: E.coli 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Kandankathiri Choornam 
(KKC) 
Streptomycin (100µg) 26 
250 15 
500 16 
1000 20 
14mm- Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
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                                                  Table10:  Organism: Klebsiella pneumonia 
 
     Sample 
Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Kandankathiri Choornam 
(KKC) 
Streptomycin (100µg) 25 
250 14 
500 16 
1000 18 
14mm- Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
                                           Table: 11   Organism: Pseudomonas aeroginosa 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Kandankathiri Choornam 
(KKC) 
Streptomycin (100µg) 30 
250 16 
500 18 
1000 24 
14mm- Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
FUNGAL LOAD 
 Table: 12 Organism: Aspergillus niger
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
 
Kandankathiri Choornam 
(KKC) 
Clotrimazole(100µg)  37 
250 15 
500 16 
1000 18 
14mm- Low sensitive, 15mm-Moderate, 16mm-Highly sensitive. 
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INTERPRETATION : 
     1. Staphylococcus aureus      - Highly sensitive in 250(µg/ml) 
     2. Escherchia coli                  - Highly sensitive in 500(µg/ml) 
     3. Klebsiella pneumoniae      -  Highly sensitive in 500(µg/ml) 
     4. Pseudomonas aeruginosa  - Highly sensitive in 250(µg/ml) 
     5. Aspergillus niger               - Highly sensitive in 500(µg/ml) 
Discussion: 
        The development of resistance against the presently available antibiotics arises the 
necessity of rediscovery of new anti-bacterial and anti-fungal agents in traditional 
systems of medicine. Different dosages of test drug against the microbes in antimicrobial 
activity of KKC was compared with Standard drug Streptomycin and Clotrimazole 
(100μg)/ml disc for the following pathogens, they are Staphylococcus aureus, Escherchia 
coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Aspergillus niger. The results 
represents KKC potentially inhibit the growth of all above organism in 250μl, 500μl and 
1000μl / disc. 14 mm – Low sensitive, 15 mm – Moderate, above 16 mm – Highly 
sensitive. The findings reveal that the Siddha drug KKC  have anti-microbial potency 
against bacterial and fungal pathogens which is used in the treatment of diseases
(117)
.  
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INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra-Red Spectroscopy) 
 
 
 
 
 
 
 
 
 
                           Fig no:5. FT-IR Graph of Kandankathari Chooranam 
         Table 13: FT-IR Interpretation of Kandankathari  Chooranam 
Frequency, cm
-1 
Bond Functional group 
3405 O-H  Stretch, H-bonded Alcohols,phenols 
2925 C-H stretch, O-H stretch Alkanes and Carboxylic 
Acid 
2854 C-H stretch, O-H stretch Alkanes and Carboxylic 
Acid 
1641 -C=C- Stretch Alkenes 
1511 N-O asymmetric stretch Nitro compounds 
1456 C-H bend, C-C Stretch (in ring) Alkenes, Aromatics 
1363 C-H rock Alkenes 
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1113 C-O Stretch, C-N Stretch Alcohols, Carboxylic acid 
Aliphatic amines 
831 C-Cl Stretch, C-H “oop”, 
 N-H wag 
Alkyl Halides, Aromatics, 
1
o
, 2
o 
amines 
617 C-Br stretch Alkyl Halide 
548 C-Br stretch Alkyl Halide 
 
DISCUSSION: 
            FTIR instrumental analysis was done. The test drug was identified to have 12 
peaks. They are the functional groups present in the trial drug Kandankathari 
Chooranam. 
            The above table shows the presence of Alcohol, Amides, Amines, Acid, 
Aromatics, Alkyl halides, Alkene, Nitro compounds and alkanes which are represents the 
peak value. 
 OH  group  has  anti-asthmatic  effect.  It  has  higher  potential towards inhibitory 
activity against airway inflammation 
(118)
. 
 Amide has mucolytic activity. It makes the mucus less thick and sticky and easier 
to cough up
(119)
. 
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SEM: (SCANNING ELECTRON MICROSCOPE)

                                    SEM images of Kandankathari Chooranam 
 
 
 
 
 
 196nm 
 
                              
                         Fig: 6.1. SEM image of 1 µm of  Kandankathari Chooranam 
 
 
 
 
 
 
 
79nm 
 
                           Fig: 6.2. SEM image of 2 µm of  Kandankathari Chooranam 
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Interpretation for SEM 
 SEM  analysis  of  the  test  drug  KKC  revealed  the presence of Nano and Micro 
particles of size 79nm, 91nm, 136nm, 196nm and 261nm.
 Micro particles are defined as particulate dispersion or solid particles with a size 
in the range of 100 to 1000nm in diameter. The above SEM studies microscopic 
resolution showed objects of sizes ranging from 5-2 microns.
 Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. Nano medicine has its benefit in the treatment 
for many chronic diseases. Nano particles are smaller in size which enhances the 
solubility and bioavailability of the drug 
(120)
.
 The particles of Nano and micro particles control and sustain the release of drug 
during the transportation and at the site of localization, alters drug distribution in 
the body and subsequent clearance of the drug so as to achieve increased drug 
therapeutic efficacy thereby bio-availability and reduced side effects.
XRD (X-Ray Diffraction studies): 
 
 
 
 
 
 
 
  
                      Fig no:7. XRD Graph of Kandankathari Chooranam 
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Interpretation: 
          The crystallin structure, the size and shape of the particles are highly dependent on 
the route of synthesis and high lights the efficacy of the drug. The nano particles may 
enhance bio absorption of the drug. 
          XRD pattern of Kandankathari chooranam shows the good crystallinity after 
calcinations process. The major diffraction peaks are identified after XRD analysis KKC 
concluded that Nano crystalline range 25-53nm in association with organic molecules 
propably plays an important role in making it biocompatible and nontoxic at therapeutic 
doses. Other elements present in KKC act as additional supplement and possibly helps in 
increase the efficacy of the formulation.
(121)
. 
ICP-OES RESULTS OF KANDANKATHARI CHOORANAM 
                          Table 14: ICP –OES Results of Kandankathari Chooranam 
 
S.NO Elements Symbol      Wavelength (nm) Concentration 
1. Aluminum (Al) 396.152 BDL 
2  Arsenic  (As) 188.979  BDL 
3 Calcium  (Ca) 315.807 01.190 mg/L 
4 Cadmium  (Cd) 228.802 BDL 
5 Copper   (Cu) 327.393 BDL 
6  Iron   (Fe) 238.204 21.554 mg/L 
8 Potassium  (k) 766.491 23. 151 mg/L 
9 Magnesium  (Mg) 285.213 01.154 mg/L 
 10 Sodium  (Na) 589.592 14.100 mg/L 
11  Nickel (Ni) 231.604 BDL 
12 Lead  (Pb) 220.353  BDL 
13 Phosphorus (P) 213.617 78.607 mg/L 
14 Zinc (Zn) 206.200 01.806 mg/L 
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DISCUSSION 
ICP-OES reveals the concentration of many physiologically important minerals 
like Ca(01.190mg/L), Fe(21.554mg/L), K(23.151mg/L), Mg(01.154mg/L), 
Na(14.100mg/L), P(78.607mg/L and Zn(01.806mg/L) in the drug Kandankathari 
Chooranam. The heavy metals like Al, As, Cd, Cu, Hg,  Pb and trace element like Ni 
were below detectable level. This reveals the safety of the drug. Hence the formulation 
Kandankathari Chooranam is extremely safe. 
Phosphorus 
 Phosphorus is an essential mineral primarily used for  growth  and  repair of body 
cells and tissues 
(121)
.
 Phosphorus is best suited for cough that occurs with asthma.
 It is indicated in the treatment of bronchial asthma 
(122)
.
Iron 
 Presence of iron in the drug has increased haemoglobin concentration in the blood 
and enhances the arterial oxygen level. The drug enhances oxygen supply, 
promotes the normal ventilation of the lungs and reduces the dyspnea.
 It also reduces airway hyperactivity and eosinophilia.
Calcium and Pottasium 
 Potassium and Calcium, cell-signaling channel plays a most important role in 
regulatory part of the respiratory system, breathing rhythm and the body’s 
response to insufficient oxygen levels 
(123)
.
 So this drug KKC stimulates normal respiratory mechanism.
  So Calcium, Potassium, Iron, Sodium, Magnesium, Zinc and phosphorus of this 
KKC drug help to achieve its activity on bronchial muscles. 
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TOXICITY STUDY RESULTS: 
Acute oral toxicity study of Kandankathari Chooranam – OECD 423  
Dose finding experiment and its behavioural Signs of acute oral  
Table:15. Observation of acute toxicity studies 
SL              Group 
              CONTROL 
Observation SL Group 
TEST GROUP 
Observation 
1 Body weight Normal 1 Body weight Normally 
increased 
 
2 Assessments of posture Normal 2 Assessments of 
posture 
Normal 
3 Signs of Convulsion 
Limb paralysis 
Normal 3 Signs of 
Convulsion 
Limb paralysis 
Absence of sign 
(-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color No significant 
color change 
7 Change in skin 
color 
No significant 
color change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 Sensitivity 
response 
Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
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Table: 16  Dose finding experiment and its behavioural Signs of Toxicity for 
Kandankathari  Chooranam 
Dose 
Mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Control + - - + - + - - - - - - - - - - - - + - 
2000mg/kg + - - + - + - - - - - - - - - - - - + - 
 
1.Alertness 2.Aggressiveness 3. Pile erection 4.Grooming 5.Gripping 6. Touch 
Response 7. Decreased Motor Activity 8.Tremors 9.Convulsions 10. Muscle 
Spasm 11. Catatonia 12. Muscle relaxant 13.Hypnosis 14.Analgesia 
15.Lacrimation 16.Exophthalmos 17.Diarrhoea 18.Writhing 19.Respiration 20. 
Mortality 
Table: 17. (Body weight Observation) 
 
 
 
 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 240.1±65.70 240.3 ± 41.11 240.6 ±02.12 
HIGH DOSE 245.3± 6.64 245.7 ±7.42 245.2 ± 2.70 
P value (p)* NS NS NS 
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Table: 18. (Water intake (ml/day) of Wistar albino rats group exposed to 
KANDANKATHARI  CHOORANAM): 
DOSE 
 
DAYS 
1 7 14 
CONTROL 53 ± 3.20 53±6.10 53 ±5.44 
HIGH DOSE 54 ±1.30 54±6.70       54 ±5.64 
P value (p)* NS NS NS 
 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Table :19. Food intake (gm/day) of Wistar albino rats group exposed to 
KANDANKATHARI  CHOORANAM 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 54.03±2.82 54.2±2.96 54.7±8.86 
High DOSE 52.6±5.44 52.4±3.20 52.4±2.64 
P value (p)* NS NS NS 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
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Interpretation of Acute toxicity studies: 
 In the acute toxicity study, the rats were treated with different concentration of 
Kandankathari Chooranam from the range of 5mg/kg to 2000mg/kg. 
 This  dose  level  did  not  produce  signs  of  toxicity,  behavioral  changes  and 
mortality in the test groups as compared to the controls when observed during 14 
days of the acute toxicity experimental period. 
 However the behavior changes, Body weight, Water intake, food intake does not 
produce much significant. Thus the results are non-significant. 
 These results showed that a single oral dose of the extract showed no mortality of      
these rats even under higher dosage levels indicating the high margin of safety of 
this extract. 
 In acute toxicity test the Kandankathari Chooranam was found to be nontoxic at 
the dose level of 2000mg/ kg body weight. 
RESULTS OF SUB-ACUTE ORAL TOXICITY 28 DAYS REPEATED DOSE 
STUDY IN RATS 
Table:20. Food (g/day) intake of mice exposed to KANDANKATHARI  
CHOORANAM: 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 1.210.1 2.060.4 2.990.10 3.00.31 3.110.22 
KKC 100 2.010.2 2.770.3 3.010.40 3.00.31 3.880.40 
KKC 200 2.890.2 2.770.20 2.330.31 2.450.26 2.970.25 
KKC 400 3.00.4 2.250.21 2.280.2 2.660.28 2.700.32 
P value (p)* NS NS NS NS NS 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
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Table:21. Water (ml/day) intake of rat exposed to KANDANKATHARI  
CHOORANAM : 
Dose 
(mg/kg/day) 
Days 
1  7 14 21 28 
Control 4.1 ± 0.4  4.30.2 4.333.14 4.50.5 4.50.4 
KKC 100 4.2 ± 0.2  4.1.0.4 4.00.2 4.30.3 4.40.3 
KKC 200 3.9 ± 0.4  4.00.5 4.20.21 4.60.2 4.70.5 
KKC 400 3.9 ± 0.7  4.70.3 4.4.0.4  4.70.4 4.8.0.4 
P value (p)* NS  NS NS NS NS 
                                     
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Table:22. Body weight changes of mice exposed to KANDANKATHARI  
CHOORANAM 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 22.373.21 24.144.09 28.212.17 27.215.11 33.321.89 
KKC 100 23.283.21 25.21 3.25 26.17 2.71 28.12 3.41 32.22 3.54 
KKC 200 24.22 2.45 29.45 3.65  30.25 3.42 32.25 2.14 33.25 2.34 
KKC 400 22.12 3.45 28.45 3.75 31.48 3.25 31.45 2.34 33.45 3.25 
P value (p)* NS NS NS NS NS 
      
 N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test)                 
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Table :23. Food  intake  (gm/day)  of   Wistar   albino   rats   group   exposed   to 
KANDANKATHARI  CHOORANAM 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 42±5.21 42.2±4.22 42.8±3.13 43.2±6.72 44±6.80 
LOW 
DOSE 
43.6±6.22 43.8±2.42 44.4±1.50 44.5±1.30 44.8±1.12 
MID DOSE 45.1±6.70 45.2±2.40 45.6±5.64 46.3±2.40 46.5±1.34 
HIGH 
DOSE 
47.4±1.45 47.6±1.34 47.8±2.36 48.1±1.70 48.1±1.62 
P value (p)* NS NS NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One way ANOVA followed by Dunnett’stest 
Table: 24. Effect of KANDANKATHARI  CHOORANAM on Haematological 
parameters in rat 
Parameter Control 100mg/kg 200mg/kg 300mg/kg P value 
(p)* 
RBC(x 
10
6
/mm
3
) 
5.20.43 5.160.86 6.71.2 6.320.92 NS 
PCV (%) 48.21.8 52.41.26 56.34.6** 52.86.4* NS 
Hb (g/dl) 150.3 151.06 16.21.8 15.461.8 NS 
WBC(mm
3
) 8422183 9567110** 9724263** 10568106** NS 
Neutrophils (%) 182 221.2** 190.9 241.6** NS 
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Mononuclear 
cells(%) 
783 772.3 781.6 730.9** NS 
Eosinophils(%) 30.3 20.08 1.60.12 2.20.4 NS 
Platelets(x 
10
3
/mm
3
) 
6456.2 75215.6** 796.317.2** 81025.4** NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One way ANOVA followed by Dunnett’stest 
Table:25. Effect of KANDANKATHARI  CHOORANAM on biochemical parameters 
in rat. 
Parameters Control 100mg/kg 200mg/kg 400mg/kg 
Protein (g/dl) 6.330.3 5.721.4 6.42.4 5.40.8 
Albumin (g/dl) 2.80.2 2.20.18 3.20.5 2.70.24 
BUN (mg/dl) 21.334.6 20.41.6 19.31.2 26.42.4 
Urea (mg/dl) 634.3 522.2 545.2 66.43.8 
Creatinine (mg/dl) 0.530.03 0.520.04 0.650.007** 0.830.04** 
Tot.Cholesterol(mg/dl) 111.5313.17 10618.2 98.67.8 121.422.8 
Triglycerides(mg/dl) 97.5614.5 84.311.2 96.215.4 96.69.8 
 LDH (IU/l) 248.16 ± 
59.05 
210.83 ± 27.4 211.5 ± 28.78 204.66 ± 50.77 
* 
Glucose (mg/dl) 113.412.2 87.29.6** 93.410.2** 126.513.4* 
Total Bilirubin (mg/dl) 0.90.08 0.720.04** 0.620.08** 0.930.12 
SGOT (U/L) 86.55.0 82.48.2 97.24.6* 91.313.3** 
SGPT(U/L) 46.56.2 36.47.3 42.45.8 37.416.2* 
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Alkaline phosphatase 
(U/L) 
48.67.2 42.613.4 52.81.2 46.33.6 
Sodium (mEq/L) 147.35.8 132.48.2** 148.410.4 128.327.2** 
Potassium (mEq/L) 5.30.4 4.60.2** 5.10.63 4.80.59 
Chloride (mEq/L) 90.060.4 88.040.2 91.50.63 91.230.59 
 
Values are expressed as mean  S.E.M (Dunnett's test). *P<0.05, **P<0.01, 
***P<0.001 vs control; N=12 
DISCUSSION: 
         The dose selected for the Sub acute toxicity study was 200mg, 400mg/kg of 
Kandankathari Chooranam 
        All the animals were free of intoxicating signs throughout the dosing period of 28 
days. No physical changes were observed throughout the dosing period. No mortality was 
observed during the whole experiment. No abnormal deviations were observed. No 
significant changes were observed in the values of different parameters studied when 
compared with controls and values obtained were within normal biological and 
laboratory limits. 
       The weights of organs and the body weight recorded did not show any significant 
differences in the treatment and the control group indicating that Kandankathari 
Chooranam was not toxic to kidney, liver and spleen. 
        There was no significant changes were observed in haemoglobin (Hb), Red blood 
cell (RBC), White blood cell (WBC), Packed cell volume (PCV), Erythrocyte 
sedimentation rate (ESR) in all the treated groups as compared to respective control 
groups. 
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HISTOPATHOLOGICAL STUDIES: 
Fig: 8 
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DISCUSSION: 
Histopathological studies were carried out on lungs, liver, kidney and spleen 
recorded. Blood samples for haematological and blood chemical analyses were taken 
from common carotid artery. 
            All rats were sacrificed after the blood collection. The internal organs and some 
tissues were observed for gross lesions. All tissues were preserved in 10% neutral 
buffered formaldehyde solution for histopathological examination. 
           The acute and sub-acute toxicity studies of KKC drug produced some significant 
changes but the values were found within normal limits. So the drug was nontoxic and 
safe. It did not produce any adverse effect. So hopefully it could be used for human 
beings. 
           The histopathology studies of acute and sub-acute toxicity shows that there is no 
toxicological abnormality seen in the vital organs after administration of the test drug 
Kandankathari Chooranam. Thus the safety of the drug is revealed so that it can be 
administered for long time without any side effects. 
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4.4 PHARMACOLOGICAL STUDY 
BRONCHODILATOR ACTIVITY 
                    Table: 26. Bronchodilator activity of Kandankathari Chooranam 
S. No Group Onset  of Convulsion  
in sec. 
% protection 
1 Control 91.45±0.093 -- 
2 Standard (Chlopheniramine 
maleate) 
1054.2±2.15* 93.6 
3 Kandankathari Chooranam 
(200mg/kg) 
262.3±1.76** 69.34 
4 Kandankathari Chooranam 
(400mg/kg) 
456.4.±1.18** 81.32 
Values are mean ±S.E.M. (n=6) *p<0.01, **p<0.001compared with the control 
animals 
                              BRONCHODILATOR ACTIVITY OF KKC
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               Chart  no. 2. Bronchodilator activity of Kandankathari Chooranam 
DISCUSSION: From the above results, we can confirm that KKC possesses 
bronchodilator activity nearer to fifty percentage when compared with Chlorpheniramine 
maleate as a standard drug. 
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ANTI-HISTAMINE ACTIVITY: 
Table: 27. Anti-Histamine effect of Kandankathari Chooranam 
S.No Grouping 
Area of Protection From 
exudation of Dye in mm 
1. Control 456.94± 1.66 
2. Cetirizine (STD) 139.11± 0.99
** 
3. Kandankathari Chooranam 200mg 198.02± 3.82 
4. Kandankathari Chooranam 400mg 154.61± 0.92
* 
Values are expressed as mean  S.E.M (Dunnett's test). *P<0.05, **P<0.01, 
***P<0.001 vs control, N = 6 
 
       Chart no.3. Anti-Histamine activity of Kandankathari Chooranam 
DISCUSSION 
            Mediators like histamine, serotonin and acetylcholine are implicated in various 
ways in the pathogenesis of Asthma. Histamine is the most implicates mediator in 
broncho constriction that accompany asthma although the role of serotonin in asthma is 
uncertain. KKC inhibited the histamine induced bronchospasm (vascular permeability) in 
rats, when compare with cetrizine as standard. Here, KKC possesses the Anti-histamine 
activity. 
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ANTI OXIDANT ACTIVITY: 
Table: 28. DPPH Assay of Kandankathari  Chooranam 
Sample Concentration 
mg/dl 
Absorbance 
Percentage of 
Inhibition 
Drug Standard Drug Standard 
CONTROL 0.3547 1.7983 - 0.00 
          12.5 1.2314 1.4044 20.69  21.90            
           25 0.9523  1.0782 39.84 40.04 
           50 0.5029  0.7121 56.33 60.40 
          100 0.1765  0.2921 66.68 83.75 
          200 0.0124  0.0692 85.85 96.15 
 *µg/ml: microgram per millilitre. Drug:KKC (41.3211µg/µl). Standard: Ascorbic 
acid (10mg/ml DMSO) 
 
Chart no.4. Anti-Oxidant activity of Kandankathari Chooranam 
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 DPPH stable free radical method is an easy, rapid and sensitive way to survey 
the antioxidant activity of KKC extract. The antioxidant molecules can quench DPPH 
free radicals by providing hydrogen atom or by electron donation and a colorless 
stable molecule 1, 1 diphenyl-2-picrylhydrazil is formed and as a result of which the 
absorbance at 517nm of the solution is decreased. In the present study, the KKC 
extract was analyzed was able to decolorize DPPH and the free radical scavenging 
activity was expressed as the percentage decrease in absorbance. In the present study, 
the extract of KKC was found to possess concentration dependent scavenging activity 
on DPPH radicals. The values of DPPH free radical scavenging activity of the KKC 
extract was given in (Table No.20). The extract of KKC showed the highest DPPH 
scavenging activity (85.85%) at 200µg/ml and the lowest percentage of inhibition 
(20.69%) at 12.5µg/ml. Ascorbic acid (Standard) showed highest percentage of 
inhibition (96.15%) at 200µg/ml and the lowest percentage of inhibition (21.90%) at 
12.5µg/ml. This indicated that % of inhibition increased with increase in 
concentration of both the standard and KKC extract. The KKC extract has more or 
less equal DPPH scavenging activity when compared to the standard. From the 
present study, it was concluded that the KKC extract has a marked Antioxidant  
activity at higher  concentrations. 
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6. CONCLUSION 
The trial drug Kandankathari Chooranam was selected from the classical Siddha 
literature, “Agathiyar Attavanai Vagadam” for the evaluation of safety and efficacy of the 
drug in Swasakasam (Bronchial asthma). 
The trial drug was identified and authenticated by the botanist and experts of 
Department of Gunapadam, GSMC Chennai. After the purification of the raw drugs by 
Sarakku  Suthi Sei Muraigal,  the trail drug Kandankathari Chooranam was prepared 
according to the Siddha classical literature. The purification process of this drug possible 
to eliminates their toxins and increases its efficacy and the grinding process of this drug 
helps to change the particle size of the drug for its better bio availability. 
Phytochemical analysis of the drug shows presences of Glycosides, Saponins, 
Carbohydrates, Flavonoids, Diterpenes and Gum and Mucilage. Plant steroids are 
important to cure the chronic inflammatory diseases like Bronchial Asthma. Glycosides 
inhibit eosinophil accumulation in tissue and allergic inflammation. Repair of epithelial 
tissue injury in asthma was made by carbohydrates. Saponin quickens the expulsion of 
mucus from the lungs. 
Biochemical analysis of basic radicals confirms the presence of Iron, Zinc, 
Potassium and Magnesium. Iron enhances oxygen supply and promotes the normal 
ventilation of the lungs and reduces the dyspnea. Magnesium ions are responsible for 
bronchodilator and anticholinergic action which helps in acute asthma. 
Zinc and potassium cell-signaling channel plays almost important role in 
regulatory part of the respiratory system. So, this drug stimulates normal respiratory 
mechanism. 
Biochemical analysis of acid radicals shows the presence of Chloride, Phosphate. 
Chloride plays critical roles in inflammatory airway diseases such as Bronchial asthma. 
Phosphate reduces the histamine release by activated mast cells. 
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Instrumental analysis FT-IR results showed presence of Alcohol, Amide, Amine, 
Acid, Aromatic, Alkyl halides, Alkene, Ether and Alkane groups. Alcohol group has anti-
asthmatic effect. It has higher potential towards inhibitory activity against airway 
inflammation. Amide has mucolytic activity. It makes the mucus less thick and sticky and 
easier to cough up. 
SEM picture represents Nano and micro particle varying sizes from 79nm to 
261nm. It represents the drug is more absorbable and easily to reach the cell. The micro 
and Nano particles present in the drug results in increased drug therapeutic efficacy 
thereby bio-availability and reduced side effects. 
ICP-OES results show the presence of Phosphorus, Iron, Sodium, Calcium and 
Potassium. Phosphorus is best suited for cough that occurs with asthma. So, it is indicated 
in the treatment of bronchial asthma. 
Kandankathari Chooranam did not produce any oral acute or sub-acute toxicity in 
rats. So, the drug was non-toxic and safe. The histopathology studies of acute and sub-
acute toxicity show that there is no toxicological abnormality seen in the vital organs 
after administration of the test drug Kandankathari Chooranam. 
Kandankathari Chooranam could be conformed as No-Observed-Adverse Effect 
Level (NOAEL) drug as it acts harmless under normal usage and to be of no 
toxicological concern. 
After evaluate the safety the drug, the Bronchodilator and anti-histaminic property 
of Kandankathari Chooranam is elaborated. So, it can be concluded that this drug 
inhibits the tone of tracheal and bronchial muscles and thus has a bronchodilator action. It 
is possible that anti-histamine activity of the Kandankathari Chooranam mainly involves 
inhibiting the histamine induced bronchospasm. The KKC extract has more or less equal 
DPPH scavenging activity when compared to the standard. The KKC extract has a 
marked antioxidant activity at higher concentrations. 
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From the above scientific evaluation, the author concludes that the drug 
Kandankathari Chooranam is proficient with the new hope in the treatment of Bronchial 
asthma which is cost effective and has fair preparation method. 
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7. SUMMARY 
 
 Siddhars improve their long life and virtual power through the modification of 
Pranan. Imbalance in Pranan can cause the vitiation of three humours, it can cause 
bronchoconstriction. Siddhar describes this etiology of symptoms in literature named as a 
disease Swasakasam. 
 Hence the author conducts the detailed scientific validation of Kandankathari 
Chooranam for Bronchodilator activity, Anti-histamine activity and Anti-oxidant 
activity. 
 To collect the information about the drug in various classical Siddha and modern 
text books, literature was referred. From them, the author came to an idea about the drug 
and its efficacy on bronchial asthma.

 The Phytochemical analysis of the drug evaluates that it contains Carbohydrates, 
Glycosides, Saponins, Flavonoids, Triterpene and Gum and Mucilage which contributes 
much in relieving the symptoms of bronchial asthma.

 Bio-Chemical analysis of the drug contains Iron, Magnesium, Pottasium, 
Calcium, Chloride and Phosphate which involves improving normal respiratory function 
in bronchial asthma. 
 ICP-OES result shows the presence of Phosphorus, Iron, Sodium, Calcium and 
Potassium which involves in treating the symptoms of Kandankathari Chooranam. 
 SEM analysis represents the drug contains Nano and micro particles.

 The   preclinical   study   showed  that    the   drug   has  got  safe  and  significant  
Bronchodilator, Anti-histamine activity and Anti-oxidant activities. 
 An incredible action of this drug value against the disease of Bronchial asthma 
has been revealed from this study of Kandankathari Chooranam. This must be 
implicated in the future clinical studies and preclinical chronic toxicity studies.

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8.  FUTURE SCOPE 
 
The trial drug Kandankathari Chooranam has its own potency in treating 
Bronchial asthma in animal model which has been established in this study. An incredible 
action of this drug value against the disease of Bronchial asthma has been revealed from 
this study of Kandankathari Chooranam. This must be implicated in the future clinical 
studies and preclinical chronic toxicity studies. 
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